JP2019503172A5 - - Google Patents

Info

Publication number

JP2019503172A5

JP2019503172A5 JP2018533745A JP2018533745A JP2019503172A5 JP 2019503172 A5 JP2019503172 A5 JP 2019503172A5 JP 2018533745 A JP2018533745 A JP 2018533745A JP 2018533745 A JP2018533745 A JP 2018533745A JP 2019503172 A5 JP2019503172 A5 JP 2019503172A5

Authority

JP

Japan

Prior art keywords

domain

amino acid

antibody

residue

residues

Prior art date

2016-12-28

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000006467 substitution reaction Methods 0.000 claims description 373
• 235000001014 amino acid Nutrition 0.000 claims description 337
• 239000000427 antigen Substances 0.000 claims description 118
• 108091007433 antigens Proteins 0.000 claims description 116
• 102000036639 antigens Human genes 0.000 claims description 116
• 150000001413 amino acids Chemical group 0.000 claims description 57
• 108060003951 Immunoglobulin Proteins 0.000 claims description 56
• 102000018358 immunoglobulin Human genes 0.000 claims description 56
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 35
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 29
• 150000007523 nucleic acids Chemical class 0.000 claims description 29
• 102000039446 nucleic acids Human genes 0.000 claims description 28
• 108020004707 nucleic acids Proteins 0.000 claims description 28
• 206010028980 Neoplasm Diseases 0.000 claims description 27
• 235000003704 aspartic acid Nutrition 0.000 claims description 25
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 25
• 239000013604 expression vector Substances 0.000 claims description 24
• 201000010099 disease Diseases 0.000 claims description 23
• 125000003729 nucleotide group Chemical group 0.000 claims description 23
• 201000011510 cancer Diseases 0.000 claims description 22
• 239000002773 nucleotide Substances 0.000 claims description 22
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 20
• 239000004472 Lysine Substances 0.000 claims description 19
• 238000004519 manufacturing process Methods 0.000 claims description 16
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims description 15
• 239000000203 mixture Substances 0.000 claims description 12
• 238000011282 treatment Methods 0.000 claims description 12
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 11
• 235000004279 alanine Nutrition 0.000 claims description 11
• 239000004475 Arginine Substances 0.000 claims description 10
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 10
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 10
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 9
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 9
• 235000013922 glutamic acid Nutrition 0.000 claims description 9
• 239000004220 glutamic acid Substances 0.000 claims description 9
• 208000023275 Autoimmune disease Diseases 0.000 claims description 8
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
• 239000004474 valine Substances 0.000 claims description 8
• 238000012258 culturing Methods 0.000 claims description 6
• 206010020751 Hypersensitivity Diseases 0.000 claims description 5
• 208000027866 inflammatory disease Diseases 0.000 claims description 5
• 230000004044 response Effects 0.000 claims description 5
• 238000001514 detection method Methods 0.000 claims description 2
• 230000002062 proliferating effect Effects 0.000 claims description 2
• 208000030961 allergic reaction Diseases 0.000 claims 1
• 230000000116 mitigating effect Effects 0.000 claims 1
• 244000045947 parasite Species 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 125000003275 alpha amino acid group Chemical group 0.000 description 309
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 180
• 210000004027 cell Anatomy 0.000 description 155
• 230000027455 binding Effects 0.000 description 95
• 108090000623 proteins and genes Proteins 0.000 description 86
• 108090000765 processed proteins & peptides Proteins 0.000 description 74
• 230000035772 mutation Effects 0.000 description 64
• 102000004169 proteins and genes Human genes 0.000 description 63
• 102000004196 processed proteins & peptides Human genes 0.000 description 58
• 235000018102 proteins Nutrition 0.000 description 53
• 229940024606 amino acid Drugs 0.000 description 51
• 229920001184 polypeptide Polymers 0.000 description 51
• 239000013598 vector Substances 0.000 description 47
• 239000012634 fragment Substances 0.000 description 44
• 238000000034 method Methods 0.000 description 41
• -1 his Chemical compound 0.000 description 32
• 102100040247 Tumor necrosis factor Human genes 0.000 description 25
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 21
• 230000013595 glycosylation Effects 0.000 description 21
• 238000006206 glycosylation reaction Methods 0.000 description 21
• 208000011580 syndromic disease Diseases 0.000 description 21
• 102000004127 Cytokines Human genes 0.000 description 20
• 108090000695 Cytokines Proteins 0.000 description 20
• 230000004048 modification Effects 0.000 description 20
• 238000012986 modification Methods 0.000 description 20
• 108020004414 DNA Proteins 0.000 description 19
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 18
• 241000588724 Escherichia coli Species 0.000 description 18
• 102000003816 Interleukin-13 Human genes 0.000 description 18
• 108090000176 Interleukin-13 Proteins 0.000 description 18
• 230000001363 autoimmune Effects 0.000 description 18
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 15
• 229940002612 prodrug Drugs 0.000 description 15
• 239000000651 prodrug Substances 0.000 description 15
• 108010076504 Protein Sorting Signals Proteins 0.000 description 14
• 125000000539 amino acid group Chemical group 0.000 description 14
• 239000002609 medium Substances 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 230000006870 function Effects 0.000 description 13
• 239000000833 heterodimer Substances 0.000 description 13
• 239000007790 solid phase Substances 0.000 description 13
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 12
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
• 238000003556 assay Methods 0.000 description 12
• 239000003795 chemical substances by application Substances 0.000 description 12
• 230000002349 favourable effect Effects 0.000 description 12
• 230000001404 mediated effect Effects 0.000 description 12
• 239000013612 plasmid Substances 0.000 description 12
• 239000002202 Polyethylene glycol Substances 0.000 description 11
• 208000010668 atopic eczema Diseases 0.000 description 11
• 230000015572 biosynthetic process Effects 0.000 description 11
• 230000001684 chronic effect Effects 0.000 description 11
• 208000035475 disorder Diseases 0.000 description 11
• 239000012636 effector Substances 0.000 description 11
• 229940072221 immunoglobulins Drugs 0.000 description 11
• 230000003993 interaction Effects 0.000 description 11
• 229960003347 obinutuzumab Drugs 0.000 description 11
• 229920001223 polyethylene glycol Polymers 0.000 description 11
• 241000894007 species Species 0.000 description 11
• 108010087819 Fc receptors Proteins 0.000 description 10
• 102000009109 Fc receptors Human genes 0.000 description 10
• 206010018364 Glomerulonephritis Diseases 0.000 description 10
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 10
• 206010003246 arthritis Diseases 0.000 description 10
• 229940127089 cytotoxic agent Drugs 0.000 description 10
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 9
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 9
• 206010061218 Inflammation Diseases 0.000 description 9
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 9
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 9
• 230000001154 acute effect Effects 0.000 description 9
• 230000000172 allergic effect Effects 0.000 description 9
• 239000003814 drug Substances 0.000 description 9
• 229940079593 drug Drugs 0.000 description 9
• 230000000694 effects Effects 0.000 description 9
• 230000012010 growth Effects 0.000 description 9
• 230000004054 inflammatory process Effects 0.000 description 9
• 201000008383 nephritis Diseases 0.000 description 9
• 229960002087 pertuzumab Drugs 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 102100036302 C-C chemokine receptor type 6 Human genes 0.000 description 8
• 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 8
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 8
• 108091028043 Nucleic acid sequence Proteins 0.000 description 8
• 102000035195 Peptidases Human genes 0.000 description 8
• 108091005804 Peptidases Proteins 0.000 description 8
• 239000004365 Protease Substances 0.000 description 8
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
• 230000001472 cytotoxic effect Effects 0.000 description 8
• 210000004602 germ cell Anatomy 0.000 description 8
• 230000002401 inhibitory effect Effects 0.000 description 8
• 238000000746 purification Methods 0.000 description 8
• 230000010076 replication Effects 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 7
• 102100036305 C-C chemokine receptor type 8 Human genes 0.000 description 7
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 7
• 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 description 7
• 108010002616 Interleukin-5 Proteins 0.000 description 7
• 102000000743 Interleukin-5 Human genes 0.000 description 7
• 239000002246 antineoplastic agent Substances 0.000 description 7
• 230000001580 bacterial effect Effects 0.000 description 7
• 229960000397 bevacizumab Drugs 0.000 description 7
• 231100000433 cytotoxic Toxicity 0.000 description 7
• 238000000855 fermentation Methods 0.000 description 7
• 230000004151 fermentation Effects 0.000 description 7
• 229960002989 glutamic acid Drugs 0.000 description 7
• 229960000485 methotrexate Drugs 0.000 description 7
• 229960003301 nivolumab Drugs 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 230000035897 transcription Effects 0.000 description 7
• 102100034065 Atypical chemokine receptor 4 Human genes 0.000 description 6
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 6
• 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 6
• 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 description 6
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 6
• 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 6
• 102000003810 Interleukin-18 Human genes 0.000 description 6
• 108090000171 Interleukin-18 Proteins 0.000 description 6
• 102000004388 Interleukin-4 Human genes 0.000 description 6
• 108090000978 Interleukin-4 Proteins 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 6
• 241000721454 Pemphigus Species 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 6
• 206010047115 Vasculitis Diseases 0.000 description 6
• 230000002378 acidificating effect Effects 0.000 description 6
• 239000003242 anti bacterial agent Substances 0.000 description 6
• 208000006673 asthma Diseases 0.000 description 6
• 238000004587 chromatography analysis Methods 0.000 description 6
• 230000004540 complement-dependent cytotoxicity Effects 0.000 description 6
• 230000002950 deficient Effects 0.000 description 6
• 108020001096 dihydrofolate reductase Proteins 0.000 description 6
• 239000003623 enhancer Substances 0.000 description 6
• 230000006698 induction Effects 0.000 description 6
• 210000004379 membrane Anatomy 0.000 description 6
• 239000012528 membrane Substances 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 230000009870 specific binding Effects 0.000 description 6
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 229960005486 vaccine Drugs 0.000 description 6
• 230000003612 virological effect Effects 0.000 description 6
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 5
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
• UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 5
• 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 5
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 5
• 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 description 5
• 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 description 5
• 102100033461 Interleukin-17A Human genes 0.000 description 5
• 102000004889 Interleukin-6 Human genes 0.000 description 5
• 108090001005 Interleukin-6 Proteins 0.000 description 5
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 5
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
• 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 description 5
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 5
• 229910019142 PO4 Inorganic materials 0.000 description 5
• 229930012538 Paclitaxel Natural products 0.000 description 5
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 5
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 5
• 241000700605 Viruses Species 0.000 description 5
• 239000005557 antagonist Substances 0.000 description 5
• 229940088710 antibiotic agent Drugs 0.000 description 5
• 150000001720 carbohydrates Chemical class 0.000 description 5
• 235000014633 carbohydrates Nutrition 0.000 description 5
• 238000010367 cloning Methods 0.000 description 5
• 239000000356 contaminant Substances 0.000 description 5
• 239000003246 corticosteroid Substances 0.000 description 5
• 239000000430 cytokine receptor antagonist Substances 0.000 description 5
• 239000002254 cytotoxic agent Substances 0.000 description 5
• 231100000599 cytotoxic agent Toxicity 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 239000000539 dimer Substances 0.000 description 5
• 229960004679 doxorubicin Drugs 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
• 229910052739 hydrogen Inorganic materials 0.000 description 5
• 230000028993 immune response Effects 0.000 description 5
• 210000000987 immune system Anatomy 0.000 description 5
• 238000013507 mapping Methods 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 235000015097 nutrients Nutrition 0.000 description 5
• 229960001592 paclitaxel Drugs 0.000 description 5
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
• 239000010452 phosphate Substances 0.000 description 5
• 235000021317 phosphate Nutrition 0.000 description 5
• 235000019419 proteases Nutrition 0.000 description 5
• 230000009885 systemic effect Effects 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 230000009261 transgenic effect Effects 0.000 description 5
• 238000011144 upstream manufacturing Methods 0.000 description 5
• 229960004528 vincristine Drugs 0.000 description 5
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 5
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 5
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 4
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
• 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 4
• 102100037853 C-C chemokine receptor type 4 Human genes 0.000 description 4
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 4
• 102100023700 C-C motif chemokine 16 Human genes 0.000 description 4
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 4
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 4
• 102100021933 C-C motif chemokine 25 Human genes 0.000 description 4
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 4
• 102100021936 C-C motif chemokine 27 Human genes 0.000 description 4
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 4
• 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 4
• 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 4
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 4
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 4
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 4
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 4
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 4
• 101150013553 CD40 gene Proteins 0.000 description 4
• 102100025221 CD70 antigen Human genes 0.000 description 4
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 4
• 102100035294 Chemokine XC receptor 1 Human genes 0.000 description 4
• 208000015943 Coeliac disease Diseases 0.000 description 4
• 201000004624 Dermatitis Diseases 0.000 description 4
• 238000002965 ELISA Methods 0.000 description 4
• 101150029707 ERBB2 gene Proteins 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 102000003951 Erythropoietin Human genes 0.000 description 4
• 108090000394 Erythropoietin Proteins 0.000 description 4
• 108010008165 Etanercept Proteins 0.000 description 4
• 102100028417 Fibroblast growth factor 12 Human genes 0.000 description 4
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 4
• 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 4
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 4
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 4
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 4
• 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 description 4
• 101000798902 Homo sapiens Atypical chemokine receptor 4 Proteins 0.000 description 4
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
• 101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 description 4
• 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 4
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 4
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 4
• 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 description 4
• 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 description 4
• 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 4
• 101000916059 Homo sapiens C-X-C chemokine receptor type 2 Proteins 0.000 description 4
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 4
• 101000746022 Homo sapiens CX3C chemokine receptor 1 Proteins 0.000 description 4
• 101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 description 4
• 101000917234 Homo sapiens Fibroblast growth factor 12 Proteins 0.000 description 4
• 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 4
• 101000843810 Homo sapiens Hydroxycarboxylic acid receptor 1 Proteins 0.000 description 4
• 101100232357 Homo sapiens IL13RA1 gene Proteins 0.000 description 4
• 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 4
• 101001017968 Homo sapiens Leukotriene B4 receptor 1 Proteins 0.000 description 4
• 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 4
• 102100030642 Hydroxycarboxylic acid receptor 1 Human genes 0.000 description 4
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 4
• 102000003814 Interleukin-10 Human genes 0.000 description 4
• 108090000174 Interleukin-10 Proteins 0.000 description 4
• 102000003815 Interleukin-11 Human genes 0.000 description 4
• 108090000177 Interleukin-11 Proteins 0.000 description 4
• 102000013462 Interleukin-12 Human genes 0.000 description 4
• 108010065805 Interleukin-12 Proteins 0.000 description 4
• 102100033101 Interleukin-17B Human genes 0.000 description 4
• 102100036678 Interleukin-27 subunit alpha Human genes 0.000 description 4
• 102000004890 Interleukin-8 Human genes 0.000 description 4
• 108090001007 Interleukin-8 Proteins 0.000 description 4
• 108010002335 Interleukin-9 Proteins 0.000 description 4
• 102000000585 Interleukin-9 Human genes 0.000 description 4
• 102000015696 Interleukins Human genes 0.000 description 4
• 108010063738 Interleukins Proteins 0.000 description 4
• 208000029523 Interstitial Lung disease Diseases 0.000 description 4
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 4
• 102000016267 Leptin Human genes 0.000 description 4
• 108010092277 Leptin Proteins 0.000 description 4
• 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 208000005225 Opsoclonus-Myoclonus Syndrome Diseases 0.000 description 4
• 201000004681 Psoriasis Diseases 0.000 description 4
• 208000034189 Sclerosis Diseases 0.000 description 4
• 210000001744 T-lymphocyte Anatomy 0.000 description 4
• 108010000499 Thromboplastin Proteins 0.000 description 4
• 102100030859 Tissue factor Human genes 0.000 description 4
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 4
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 4
• 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 4
• 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 4
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 4
• 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 4
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 4
• 206010046851 Uveitis Diseases 0.000 description 4
• 102100038234 Vascular endothelial growth factor D Human genes 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 230000004913 activation Effects 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 229960000723 ampicillin Drugs 0.000 description 4
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 230000000890 antigenic effect Effects 0.000 description 4
• 201000008937 atopic dermatitis Diseases 0.000 description 4
• 230000005784 autoimmunity Effects 0.000 description 4
• 229940022399 cancer vaccine Drugs 0.000 description 4
• 238000009566 cancer vaccine Methods 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 230000000295 complement effect Effects 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 4
• 238000010494 dissociation reaction Methods 0.000 description 4
• 230000005593 dissociations Effects 0.000 description 4
• 229960003668 docetaxel Drugs 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 229940105423 erythropoietin Drugs 0.000 description 4
• 229960002949 fluorouracil Drugs 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 238000005734 heterodimerization reaction Methods 0.000 description 4
• 229940088597 hormone Drugs 0.000 description 4
• 239000005556 hormone Substances 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
• 230000001900 immune effect Effects 0.000 description 4
• 230000005847 immunogenicity Effects 0.000 description 4
• 239000003018 immunosuppressive agent Substances 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 230000002757 inflammatory effect Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 210000003292 kidney cell Anatomy 0.000 description 4
• 229940039781 leptin Drugs 0.000 description 4
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 4
• 239000012160 loading buffer Substances 0.000 description 4
• 206010025135 lupus erythematosus Diseases 0.000 description 4
• 238000004949 mass spectrometry Methods 0.000 description 4
• 201000006417 multiple sclerosis Diseases 0.000 description 4
• 229910052757 nitrogen Inorganic materials 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 208000033808 peripheral neuropathy Diseases 0.000 description 4
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 4
• 238000003127 radioimmunoassay Methods 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 description 4
• 229960004641 rituximab Drugs 0.000 description 4
• 239000000377 silicon dioxide Substances 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 150000003431 steroids Chemical class 0.000 description 4
• 239000013589 supplement Substances 0.000 description 4
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 4
• 239000003053 toxin Substances 0.000 description 4
• 231100000765 toxin Toxicity 0.000 description 4
• 108700012359 toxins Proteins 0.000 description 4
• 230000009466 transformation Effects 0.000 description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 3
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 3
• 229920000936 Agarose Polymers 0.000 description 3
• 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 3
• 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 102100023995 Beta-nerve growth factor Human genes 0.000 description 3
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 3
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 3
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 3
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 3
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 3
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 3
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 3
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 3
• 102100032937 CD40 ligand Human genes 0.000 description 3
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 3
• 208000002691 Choroiditis Diseases 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 206010009900 Colitis ulcerative Diseases 0.000 description 3
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 3
• 102100035298 Cytokine SCM-1 beta Human genes 0.000 description 3
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
• 206010012438 Dermatitis atopic Diseases 0.000 description 3
• 206010012442 Dermatitis contact Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 102000001301 EGF receptor Human genes 0.000 description 3
• 108060006698 EGF receptor Proteins 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• 206010014950 Eosinophilia Diseases 0.000 description 3
• 102100023688 Eotaxin Human genes 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 108010039471 Fas Ligand Protein Proteins 0.000 description 3
• 102100020997 Fractalkine Human genes 0.000 description 3
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 3
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 3
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 3
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 3
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 3
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 3
• 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 description 3
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 3
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 3
• 101000804771 Homo sapiens Cytokine SCM-1 beta Proteins 0.000 description 3
• 101000854520 Homo sapiens Fractalkine Proteins 0.000 description 3
• 101001010600 Homo sapiens Interleukin-12 subunit alpha Proteins 0.000 description 3
• 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 description 3
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 3
• 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 description 3
• 101000742599 Homo sapiens Vascular endothelial growth factor D Proteins 0.000 description 3
• 108010000521 Human Growth Hormone Proteins 0.000 description 3
• 102000002265 Human Growth Hormone Human genes 0.000 description 3
• 239000000854 Human Growth Hormone Substances 0.000 description 3
• 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 3
• 208000010159 IgA glomerulonephritis Diseases 0.000 description 3
• 206010021263 IgA nephropathy Diseases 0.000 description 3
• 108010073807 IgG Receptors Proteins 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 3
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 102000003777 Interleukin-1 beta Human genes 0.000 description 3
• 108090000193 Interleukin-1 beta Proteins 0.000 description 3
• 102100030698 Interleukin-12 subunit alpha Human genes 0.000 description 3
• 108090000172 Interleukin-15 Proteins 0.000 description 3
• 102000003812 Interleukin-15 Human genes 0.000 description 3
• 101800003050 Interleukin-16 Proteins 0.000 description 3
• 102000049772 Interleukin-16 Human genes 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 108010002386 Interleukin-3 Proteins 0.000 description 3
• 102000000646 Interleukin-3 Human genes 0.000 description 3
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
• 206010025280 Lymphocytosis Diseases 0.000 description 3
• 108090000157 Metallothionein Proteins 0.000 description 3
• 108010006519 Molecular Chaperones Proteins 0.000 description 3
• 102000005431 Molecular Chaperones Human genes 0.000 description 3
• 208000000112 Myalgia Diseases 0.000 description 3
• 229930193140 Neomycin Natural products 0.000 description 3
• 206010029164 Nephrotic syndrome Diseases 0.000 description 3
• 208000002193 Pain Diseases 0.000 description 3
• 108090000526 Papain Proteins 0.000 description 3
• 201000011152 Pemphigus Diseases 0.000 description 3
• 208000003971 Posterior uveitis Diseases 0.000 description 3
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
• 102000014128 RANK Ligand Human genes 0.000 description 3
• 108010025832 RANK Ligand Proteins 0.000 description 3
• 206010063837 Reperfusion injury Diseases 0.000 description 3
• IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 3
• 230000018199 S phase Effects 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
• 208000005718 Stomach Neoplasms Diseases 0.000 description 3
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 3
• 102100035721 Syndecan-1 Human genes 0.000 description 3
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 3
• 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 description 3
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 3
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 3
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 3
• 201000006704 Ulcerative Colitis Diseases 0.000 description 3
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
• 230000003213 activating effect Effects 0.000 description 3
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 3
• 208000007502 anemia Diseases 0.000 description 3
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 230000001886 ciliary effect Effects 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 206010009887 colitis Diseases 0.000 description 3
• 239000002299 complementary DNA Substances 0.000 description 3
• 229960004397 cyclophosphamide Drugs 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
• 229960002433 cysteine Drugs 0.000 description 3
• 102000003675 cytokine receptors Human genes 0.000 description 3
• 108010057085 cytokine receptors Proteins 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 229960000975 daunorubicin Drugs 0.000 description 3
• CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
• 206010012601 diabetes mellitus Diseases 0.000 description 3
• 206010014599 encephalitis Diseases 0.000 description 3
• 201000002491 encephalomyelitis Diseases 0.000 description 3
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 3
• 206010017758 gastric cancer Diseases 0.000 description 3
• 238000001502 gel electrophoresis Methods 0.000 description 3
• 208000006454 hepatitis Diseases 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 239000001257 hydrogen Substances 0.000 description 3
• 229960003444 immunosuppressant agent Drugs 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 201000006747 infectious mononucleosis Diseases 0.000 description 3
• 102000006495 integrins Human genes 0.000 description 3
• 108010044426 integrins Proteins 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• RGLRXNKKBLIBQS-XNHQSDQCSA-N leuprolide acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 RGLRXNKKBLIBQS-XNHQSDQCSA-N 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 125000005647 linker group Chemical group 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 229960001428 mercaptopurine Drugs 0.000 description 3
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 229960004857 mitomycin Drugs 0.000 description 3
• 229960004927 neomycin Drugs 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 229940055729 papain Drugs 0.000 description 3
• 235000019834 papain Nutrition 0.000 description 3
• 208000012111 paraneoplastic syndrome Diseases 0.000 description 3
• 239000002245 particle Substances 0.000 description 3
• 201000001976 pemphigus vulgaris Diseases 0.000 description 3
• VJZLQIPZNBPASX-OJJGEMKLSA-L prednisolone sodium phosphate Chemical compound [Na+].[Na+].O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COP([O-])([O-])=O)[C@@H]4[C@@H]3CCC2=C1 VJZLQIPZNBPASX-OJJGEMKLSA-L 0.000 description 3
• XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
• 229960004618 prednisone Drugs 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 210000001236 prokaryotic cell Anatomy 0.000 description 3
• 230000017854 proteolysis Effects 0.000 description 3
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
• 208000002574 reactive arthritis Diseases 0.000 description 3
• 238000010188 recombinant method Methods 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 201000003068 rheumatic fever Diseases 0.000 description 3
• 238000003118 sandwich ELISA Methods 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 208000010157 sclerosing cholangitis Diseases 0.000 description 3
• 230000003248 secreting effect Effects 0.000 description 3
• 238000002741 site-directed mutagenesis Methods 0.000 description 3
• 208000017520 skin disease Diseases 0.000 description 3
• 150000003384 small molecules Chemical class 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
• 201000011549 stomach cancer Diseases 0.000 description 3
• 125000001424 substituent group Chemical group 0.000 description 3
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 3
• 229960001603 tamoxifen Drugs 0.000 description 3
• 230000005030 transcription termination Effects 0.000 description 3
• 241000701161 unidentified adenovirus Species 0.000 description 3
• 241000701447 unidentified baculovirus Species 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 3
• FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 2
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• 102100036933 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Human genes 0.000 description 2
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
• LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical class NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
• AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 2
• VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 2
• 208000030507 AIDS Diseases 0.000 description 2
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
• 206010069754 Acquired gene mutation Diseases 0.000 description 2
• 102100027211 Albumin Human genes 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 102100021266 Alpha-(1,6)-fucosyltransferase Human genes 0.000 description 2
• 102100026882 Alpha-synuclein Human genes 0.000 description 2
• 206010001889 Alveolitis Diseases 0.000 description 2
• 208000024827 Alzheimer disease Diseases 0.000 description 2
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
• 206010002198 Anaphylactic reaction Diseases 0.000 description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
• BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 2
• 201000002909 Aspergillosis Diseases 0.000 description 2
• 208000036641 Aspergillus infections Diseases 0.000 description 2
• 208000004300 Atrophic Gastritis Diseases 0.000 description 2
• 206010003694 Atrophy Diseases 0.000 description 2
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 2
• 102100022718 Atypical chemokine receptor 2 Human genes 0.000 description 2
• 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 2
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 2
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
• 108010028006 B-Cell Activating Factor Proteins 0.000 description 2
• 108010006654 Bleomycin Proteins 0.000 description 2
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 2
• 102000004152 Bone morphogenetic protein 1 Human genes 0.000 description 2
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 2
• 241000701822 Bovine papillomavirus Species 0.000 description 2
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 2
• 102100031174 C-C chemokine receptor type 10 Human genes 0.000 description 2
• 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 2
• 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 2
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 2
• 102100036303 C-C chemokine receptor type 9 Human genes 0.000 description 2
• 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 2
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 2
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 2
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
• 102100021942 C-C motif chemokine 28 Human genes 0.000 description 2
• 102100034871 C-C motif chemokine 8 Human genes 0.000 description 2
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
• 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 description 2
• 102100025277 C-X-C motif chemokine 13 Human genes 0.000 description 2
• 102100025250 C-X-C motif chemokine 14 Human genes 0.000 description 2
• 102100039396 C-X-C motif chemokine 16 Human genes 0.000 description 2
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 2
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 2
• 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 description 2
• 108010046080 CD27 Ligand Proteins 0.000 description 2
• 108010017987 CD30 Ligand Proteins 0.000 description 2
• 108010029697 CD40 Ligand Proteins 0.000 description 2
• 102100032912 CD44 antigen Human genes 0.000 description 2
• 102100040525 CKLF-like MARVEL transmembrane domain-containing protein 5 Human genes 0.000 description 2
• 102100040528 CKLF-like MARVEL transmembrane domain-containing protein 6 Human genes 0.000 description 2
• 102100039553 CKLF-like MARVEL transmembrane domain-containing protein 8 Human genes 0.000 description 2
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 2
• 102100022480 Cadherin-20 Human genes 0.000 description 2
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 101001110283 Canis lupus familiaris Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 description 2
• GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 206010008342 Cervix carcinoma Diseases 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• 108010083647 Chemokine CCL24 Proteins 0.000 description 2
• 108010083698 Chemokine CCL26 Proteins 0.000 description 2
• 108010055166 Chemokine CCL5 Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 206010008909 Chronic Hepatitis Diseases 0.000 description 2
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 2
• 102100026098 Claudin-7 Human genes 0.000 description 2
• 102100032887 Clusterin Human genes 0.000 description 2
• 108090000197 Clusterin Proteins 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 208000011231 Crohn disease Diseases 0.000 description 2
• 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 2
• 206010011715 Cyclitis Diseases 0.000 description 2
• 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
• 150000008574 D-amino acids Chemical class 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 108010092160 Dactinomycin Proteins 0.000 description 2
• MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 2
• 206010011878 Deafness Diseases 0.000 description 2
• 208000016192 Demyelinating disease Diseases 0.000 description 2
• 206010012434 Dermatitis allergic Diseases 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 206010060742 Endocrine ophthalmopathy Diseases 0.000 description 2
• 208000004232 Enteritis Diseases 0.000 description 2
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 2
• 101710139422 Eotaxin Proteins 0.000 description 2
• HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 2
• 206010015226 Erythema nodosum Diseases 0.000 description 2
• 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 2
• 102100038595 Estrogen receptor Human genes 0.000 description 2
• 101000837299 Euglena gracilis Trans-2-enoyl-CoA reductase Proteins 0.000 description 2
• 201000003542 Factor VIII deficiency Diseases 0.000 description 2
• 108010021468 Fc gamma receptor IIA Proteins 0.000 description 2
• 108010021472 Fc gamma receptor IIB Proteins 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
• 102100028413 Fibroblast growth factor 11 Human genes 0.000 description 2
• 102100035290 Fibroblast growth factor 13 Human genes 0.000 description 2
• 102100035292 Fibroblast growth factor 14 Human genes 0.000 description 2
• 102100035307 Fibroblast growth factor 16 Human genes 0.000 description 2
• 108050002072 Fibroblast growth factor 16 Proteins 0.000 description 2
• 102100035308 Fibroblast growth factor 17 Human genes 0.000 description 2
• 102100031734 Fibroblast growth factor 19 Human genes 0.000 description 2
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
• 102100031361 Fibroblast growth factor 20 Human genes 0.000 description 2
• 102000003973 Fibroblast growth factor 21 Human genes 0.000 description 2
• 108090000376 Fibroblast growth factor 21 Proteins 0.000 description 2
• 102100024802 Fibroblast growth factor 23 Human genes 0.000 description 2
• 102100028043 Fibroblast growth factor 3 Human genes 0.000 description 2
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 2
• 108090000382 Fibroblast growth factor 6 Proteins 0.000 description 2
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 2
• 102100037665 Fibroblast growth factor 9 Human genes 0.000 description 2
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
• 108010019236 Fucosyltransferases Proteins 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 101150019176 GDF10 gene Proteins 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 2
• 102000004878 Gelsolin Human genes 0.000 description 2
• 108090001064 Gelsolin Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 208000024869 Goodpasture syndrome Diseases 0.000 description 2
• 201000005569 Gout Diseases 0.000 description 2
• 206010018634 Gouty Arthritis Diseases 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 2
• 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 2
• 239000007995 HEPES buffer Substances 0.000 description 2
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 2
• 208000009292 Hemophilia A Diseases 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 101001071349 Homo sapiens 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Proteins 0.000 description 2
• 101000819490 Homo sapiens Alpha-(1,6)-fucosyltransferase Proteins 0.000 description 2
• 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 2
• 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 description 2
• 101001111439 Homo sapiens Beta-nerve growth factor Proteins 0.000 description 2
• 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 2
• 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 2
• 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 2
• 101000777558 Homo sapiens C-C chemokine receptor type 10 Proteins 0.000 description 2
• 101000980744 Homo sapiens C-C chemokine receptor type 3 Proteins 0.000 description 2
• 101000738584 Homo sapiens C-C chemokine receptor type 4 Proteins 0.000 description 2
• 101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 description 2
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 2
• 101000934394 Homo sapiens C-C chemokine receptor-like 2 Proteins 0.000 description 2
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 2
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 2
• 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 description 2
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 2
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 2
• 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 2
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 2
• 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 description 2
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 2
• 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 description 2
• 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 description 2
• 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 description 2
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 2
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 2
• 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 description 2
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 2
• 101000749437 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 5 Proteins 0.000 description 2
• 101000749435 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 6 Proteins 0.000 description 2
• 101000888512 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 8 Proteins 0.000 description 2
• 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 description 2
• 101000899459 Homo sapiens Cadherin-20 Proteins 0.000 description 2
• 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 description 2
• 101000917236 Homo sapiens Fibroblast growth factor 11 Proteins 0.000 description 2
• 101000878181 Homo sapiens Fibroblast growth factor 14 Proteins 0.000 description 2
• 101000878124 Homo sapiens Fibroblast growth factor 17 Proteins 0.000 description 2
• 101000846394 Homo sapiens Fibroblast growth factor 19 Proteins 0.000 description 2
• 101000846532 Homo sapiens Fibroblast growth factor 20 Proteins 0.000 description 2
• 101001051973 Homo sapiens Fibroblast growth factor 23 Proteins 0.000 description 2
• 101001060280 Homo sapiens Fibroblast growth factor 3 Proteins 0.000 description 2
• 101001060274 Homo sapiens Fibroblast growth factor 4 Proteins 0.000 description 2
• 101001060265 Homo sapiens Fibroblast growth factor 6 Proteins 0.000 description 2
• 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 description 2
• 101001027380 Homo sapiens Fibroblast growth factor 9 Proteins 0.000 description 2
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 2
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 2
• 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 2
• 101001035752 Homo sapiens Hydroxycarboxylic acid receptor 3 Proteins 0.000 description 2
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 2
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 2
• 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 description 2
• 101000959708 Homo sapiens Interferon alpha-4 Proteins 0.000 description 2
• 101000959704 Homo sapiens Interferon alpha-5 Proteins 0.000 description 2
• 101000959714 Homo sapiens Interferon alpha-6 Proteins 0.000 description 2
• 101000961126 Homo sapiens Interferon alpha-7 Proteins 0.000 description 2
• 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 2
• 101001002469 Homo sapiens Interferon lambda-2 Proteins 0.000 description 2
• 101001002466 Homo sapiens Interferon lambda-3 Proteins 0.000 description 2
• 101000960952 Homo sapiens Interleukin-1 receptor accessory protein Proteins 0.000 description 2
• 101000994815 Homo sapiens Interleukin-1 receptor accessory protein-like 1 Proteins 0.000 description 2
• 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 description 2
• 101001003149 Homo sapiens Interleukin-10 receptor subunit beta Proteins 0.000 description 2
• 101001003142 Homo sapiens Interleukin-12 receptor subunit beta-1 Proteins 0.000 description 2
• 101000852992 Homo sapiens Interleukin-12 subunit beta Proteins 0.000 description 2
• 101000998181 Homo sapiens Interleukin-17B Proteins 0.000 description 2
• 101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 description 2
• 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 description 2
• 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 description 2
• 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 2
• 101000852998 Homo sapiens Interleukin-27 subunit alpha Proteins 0.000 description 2
• 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 2
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 description 2
• 101001040964 Homo sapiens Interleukin-36 receptor antagonist protein Proteins 0.000 description 2
• 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 description 2
• 101000960936 Homo sapiens Interleukin-5 receptor subunit alpha Proteins 0.000 description 2
• 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 2
• 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 description 2
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 2
• 101000764535 Homo sapiens Lymphotoxin-alpha Proteins 0.000 description 2
• 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 description 2
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 2
• 101000740825 Homo sapiens Protein C10 Proteins 0.000 description 2
• 101000655540 Homo sapiens Protransforming growth factor alpha Proteins 0.000 description 2
• 101000668165 Homo sapiens RNA-binding motif, single-stranded-interacting protein 1 Proteins 0.000 description 2
• 101000651890 Homo sapiens Slit homolog 2 protein Proteins 0.000 description 2
• 101000651893 Homo sapiens Slit homolog 3 protein Proteins 0.000 description 2
• 101000684994 Homo sapiens Stromal cell-derived factor 2 Proteins 0.000 description 2
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 2
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 2
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
• 101000635958 Homo sapiens Transforming growth factor beta-2 proprotein Proteins 0.000 description 2
• 101000894525 Homo sapiens Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 description 2
• 101000795107 Homo sapiens Triggering receptor expressed on myeloid cells 1 Proteins 0.000 description 2
• 101000795117 Homo sapiens Triggering receptor expressed on myeloid cells 2 Proteins 0.000 description 2
• 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 2
• 101000830598 Homo sapiens Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 2
• 101000830600 Homo sapiens Tumor necrosis factor ligand superfamily member 13 Proteins 0.000 description 2
• 101000597779 Homo sapiens Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 2
• 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
• 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 description 2
• 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 description 2
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 2
• 101000994810 Homo sapiens X-linked interleukin-1 receptor accessory protein-like 2 Proteins 0.000 description 2
• 101001026578 Hordeum vulgare Ent-kaurenoic acid oxidase 1 Proteins 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
• 102100039356 Hydroxycarboxylic acid receptor 3 Human genes 0.000 description 2
• 108091058560 IL8 Proteins 0.000 description 2
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 2
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 2
• 108010008212 Integrin alpha4beta1 Proteins 0.000 description 2
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 2
• 102100040018 Interferon alpha-2 Human genes 0.000 description 2
• 102100039949 Interferon alpha-4 Human genes 0.000 description 2
• 102100039948 Interferon alpha-5 Human genes 0.000 description 2
• 102100040007 Interferon alpha-6 Human genes 0.000 description 2
• 102100039350 Interferon alpha-7 Human genes 0.000 description 2
• 102100020990 Interferon lambda-1 Human genes 0.000 description 2
• 102100020989 Interferon lambda-2 Human genes 0.000 description 2
• 102100020992 Interferon lambda-3 Human genes 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 102000003996 Interferon-beta Human genes 0.000 description 2
• 108090000467 Interferon-beta Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 102100039880 Interleukin-1 receptor accessory protein Human genes 0.000 description 2
• 102100034413 Interleukin-1 receptor accessory protein-like 1 Human genes 0.000 description 2
• 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 2
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 description 2
• 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 2
• 102100036701 Interleukin-12 subunit beta Human genes 0.000 description 2
• 102100035017 Interleukin-18-binding protein Human genes 0.000 description 2
• 102100039879 Interleukin-19 Human genes 0.000 description 2
• 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 description 2
• 102100036680 Interleukin-25 Human genes 0.000 description 2
• 102100036679 Interleukin-26 Human genes 0.000 description 2
• 108010066979 Interleukin-27 Proteins 0.000 description 2
• 102100039064 Interleukin-3 Human genes 0.000 description 2
• 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 description 2
• 102100021150 Interleukin-36 receptor antagonist protein Human genes 0.000 description 2
• 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 2
• 102100039881 Interleukin-5 receptor subunit alpha Human genes 0.000 description 2
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 2
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 2
• 102000000704 Interleukin-7 Human genes 0.000 description 2
• 108010002586 Interleukin-7 Proteins 0.000 description 2
• 102100026244 Interleukin-9 receptor Human genes 0.000 description 2
• 206010022941 Iridocyclitis Diseases 0.000 description 2
• 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 2
• 102100020880 Kit ligand Human genes 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• 201000001779 Leukocyte adhesion deficiency Diseases 0.000 description 2
• 108010000817 Leuprolide Proteins 0.000 description 2
• 101001089108 Lotus tetragonolobus Anti-H(O) lectin Proteins 0.000 description 2
• 102100029205 Low affinity immunoglobulin gamma Fc region receptor II-b Human genes 0.000 description 2
• 102000009151 Luteinizing Hormone Human genes 0.000 description 2
• 108010073521 Luteinizing Hormone Proteins 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102100035304 Lymphotactin Human genes 0.000 description 2
• 102100026238 Lymphotoxin-alpha Human genes 0.000 description 2
• 230000027311 M phase Effects 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 102100037273 Mammaglobin-A Human genes 0.000 description 2
• 102100037267 Mammaglobin-B Human genes 0.000 description 2
• 201000009906 Meningitis Diseases 0.000 description 2
• 102000003792 Metallothionein Human genes 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 2
• 102000029749 Microtubule Human genes 0.000 description 2
• 108091022875 Microtubule Proteins 0.000 description 2
• 102100030335 Midkine Human genes 0.000 description 2
• 208000003250 Mixed connective tissue disease Diseases 0.000 description 2
• 208000005647 Mumps Diseases 0.000 description 2
• 101000934396 Mus musculus C-C chemokine receptor-like 2 Proteins 0.000 description 2
• 101100005657 Mus musculus Ccr7 gene Proteins 0.000 description 2
• 101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 2
• 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 2
• 208000003926 Myelitis Diseases 0.000 description 2
• 206010029240 Neuritis Diseases 0.000 description 2
• 108091005461 Nucleic proteins Chemical group 0.000 description 2
• 102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 2
• 208000008589 Obesity Diseases 0.000 description 2
• CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
• 102100036154 Platelet basic protein Human genes 0.000 description 2
• 206010065159 Polychondritis Diseases 0.000 description 2
• 206010036105 Polyneuropathy Diseases 0.000 description 2
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
• 102100038957 Protein C10 Human genes 0.000 description 2
• 102100032350 Protransforming growth factor alpha Human genes 0.000 description 2
• 208000006311 Pyoderma Diseases 0.000 description 2
• 208000012322 Raynaud phenomenon Diseases 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 101710148333 Regulator of G-protein signaling 13 Proteins 0.000 description 2
• 102100021035 Regulator of G-protein signaling 18 Human genes 0.000 description 2
• 102100037415 Regulator of G-protein signaling 3 Human genes 0.000 description 2
• 101710140411 Regulator of G-protein signaling 3 Proteins 0.000 description 2
• 208000033464 Reiter syndrome Diseases 0.000 description 2
• 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 description 2
• 108020005091 Replication Origin Proteins 0.000 description 2
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
• 208000025747 Rheumatic disease Diseases 0.000 description 2
• 206010039085 Rhinitis allergic Diseases 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 206010039705 Scleritis Diseases 0.000 description 2
• 102100027339 Slit homolog 3 protein Human genes 0.000 description 2
• 108010039445 Stem Cell Factor Proteins 0.000 description 2
• 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 2
• 102100023184 Stromal cell-derived factor 2 Human genes 0.000 description 2
• 201000009594 Systemic Scleroderma Diseases 0.000 description 2
• 206010042953 Systemic sclerosis Diseases 0.000 description 2
• 108091008874 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 2
• CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 2
• 108700012411 TNFSF10 Proteins 0.000 description 2
• 229940123237 Taxane Drugs 0.000 description 2
• 239000004098 Tetracycline Substances 0.000 description 2
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
• FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 102000036693 Thrombopoietin Human genes 0.000 description 2
• 108010041111 Thrombopoietin Proteins 0.000 description 2
• 201000009365 Thymic carcinoma Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102000006601 Thymidine Kinase Human genes 0.000 description 2
• 108020004440 Thymidine kinase Proteins 0.000 description 2
• 102000011923 Thyrotropin Human genes 0.000 description 2
• 108010061174 Thyrotropin Proteins 0.000 description 2
• DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 description 2
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 2
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
• 101710183280 Topoisomerase Proteins 0.000 description 2
• 101710120037 Toxin CcdB Proteins 0.000 description 2
• 108010009583 Transforming Growth Factors Proteins 0.000 description 2
• 102000009618 Transforming Growth Factors Human genes 0.000 description 2
• 102100030737 Transforming growth factor beta-2 proprotein Human genes 0.000 description 2
• 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 2
• 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 2
• 102100021398 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 description 2
• 108700019146 Transgenes Proteins 0.000 description 2
• 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 2
• 102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 description 2
• 102100029678 Triggering receptor expressed on myeloid cells 2 Human genes 0.000 description 2
• 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 2
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 2
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 description 2
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 2
• 101710187751 Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 2
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 2
• 206010054094 Tumour necrosis Diseases 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 208000024780 Urticaria Diseases 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 102100038232 Vascular endothelial growth factor C Human genes 0.000 description 2
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 102100034412 X-linked interleukin-1 receptor accessory protein-like 2 Human genes 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000010933 acylation Effects 0.000 description 2
• 238000005917 acylation reaction Methods 0.000 description 2
• 229960002964 adalimumab Drugs 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 229940009456 adriamycin Drugs 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 201000010105 allergic rhinitis Diseases 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 2
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 2
• 230000006229 amino acid addition Effects 0.000 description 2
• ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 description 2
• 229960003437 aminoglutethimide Drugs 0.000 description 2
• KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 2
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
• 230000000202 analgesic effect Effects 0.000 description 2
• 230000036783 anaphylactic response Effects 0.000 description 2
• 208000003455 anaphylaxis Diseases 0.000 description 2
• YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 2
• 201000004612 anterior uveitis Diseases 0.000 description 2
• 230000000259 anti-tumor effect Effects 0.000 description 2
• 208000002399 aphthous stomatitis Diseases 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• 238000000429 assembly Methods 0.000 description 2
• 230000000712 assembly Effects 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 230000037444 atrophy Effects 0.000 description 2
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• KMGARVOVYXNAOF-UHFFFAOYSA-N benzpiperylone Chemical compound C1CN(C)CCC1N1C(=O)C(CC=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 KMGARVOVYXNAOF-UHFFFAOYSA-N 0.000 description 2
• QZPQTZZNNJUOLS-UHFFFAOYSA-N beta-lapachone Chemical compound C12=CC=CC=C2C(=O)C(=O)C2=C1OC(C)(C)CC2 QZPQTZZNNJUOLS-UHFFFAOYSA-N 0.000 description 2
• 229960001561 bleomycin Drugs 0.000 description 2
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
• 238000006664 bond formation reaction Methods 0.000 description 2
• 108010006025 bovine growth hormone Proteins 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
• 229960000623 carbamazepine Drugs 0.000 description 2
• FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
• 238000005277 cation exchange chromatography Methods 0.000 description 2
• 239000003729 cation exchange resin Substances 0.000 description 2
• 229940023913 cation exchange resins Drugs 0.000 description 2
• 210000002421 cell wall Anatomy 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 201000010881 cervical cancer Diseases 0.000 description 2
• 230000003196 chaotropic effect Effects 0.000 description 2
• 235000013330 chicken meat Nutrition 0.000 description 2
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
• 229960004630 chlorambucil Drugs 0.000 description 2
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
• 238000011098 chromatofocusing Methods 0.000 description 2
• 208000016644 chronic atrophic gastritis Diseases 0.000 description 2
• 208000024376 chronic urticaria Diseases 0.000 description 2
• 238000002983 circular dichroism Methods 0.000 description 2
• 229960004316 cisplatin Drugs 0.000 description 2
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
• ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 238000012875 competitive assay Methods 0.000 description 2
• 230000024203 complement activation Effects 0.000 description 2
• 230000004154 complement system Effects 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 208000010247 contact dermatitis Diseases 0.000 description 2
• 229960001334 corticosteroids Drugs 0.000 description 2
• 201000003278 cryoglobulinemia Diseases 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 230000009089 cytolysis Effects 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 229960003901 dacarbazine Drugs 0.000 description 2
• 229960000860 dapsone Drugs 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 201000001981 dermatomyositis Diseases 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 229960003957 dexamethasone Drugs 0.000 description 2
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
• FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 description 2
• 238000002296 dynamic light scattering Methods 0.000 description 2
• FSIRXIHZBIXHKT-MHTVFEQDSA-N edatrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CC(CC)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FSIRXIHZBIXHKT-MHTVFEQDSA-N 0.000 description 2
• 229950006700 edatrexate Drugs 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 229940073621 enbrel Drugs 0.000 description 2
• 206010014801 endophthalmitis Diseases 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 210000003979 eosinophil Anatomy 0.000 description 2
• 229960001904 epirubicin Drugs 0.000 description 2
• 229960000403 etanercept Drugs 0.000 description 2
• 238000012869 ethanol precipitation Methods 0.000 description 2
• 229960005420 etoposide Drugs 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 201000001155 extrinsic allergic alveolitis Diseases 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 201000005206 focal segmental glomerulosclerosis Diseases 0.000 description 2
• 231100000854 focal segmental glomerulosclerosis Toxicity 0.000 description 2
• VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 2
• 235000008191 folinic acid Nutrition 0.000 description 2
• 239000011672 folinic acid Substances 0.000 description 2
• 229940028334 follicle stimulating hormone Drugs 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 description 2
• 101150023212 fut8 gene Proteins 0.000 description 2
• 229960002870 gabapentin Drugs 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 210000003714 granulocyte Anatomy 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 231100000888 hearing loss Toxicity 0.000 description 2
• 230000010370 hearing loss Effects 0.000 description 2
• 208000016354 hearing loss disease Diseases 0.000 description 2
• 208000007475 hemolytic anemia Diseases 0.000 description 2
• 231100000283 hepatitis Toxicity 0.000 description 2
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
• 230000033444 hydroxylation Effects 0.000 description 2
• 238000005805 hydroxylation reaction Methods 0.000 description 2
• 208000022098 hypersensitivity pneumonitis Diseases 0.000 description 2
• 208000003532 hypothyroidism Diseases 0.000 description 2
• 229960001101 ifosfamide Drugs 0.000 description 2
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 2
• 208000009326 ileitis Diseases 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 230000001861 immunosuppressant effect Effects 0.000 description 2
• CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 208000000509 infertility Diseases 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 231100000535 infertility Toxicity 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 229960000598 infliximab Drugs 0.000 description 2
• 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 238000005342 ion exchange Methods 0.000 description 2
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
• BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 2
• HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 2
• 229960001691 leucovorin Drugs 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 201000002364 leukopenia Diseases 0.000 description 2
• 231100001022 leukopenia Toxicity 0.000 description 2
• 229960004338 leuprorelin Drugs 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 102000004311 liver X receptors Human genes 0.000 description 2
• 108090000865 liver X receptors Proteins 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 229940040129 luteinizing hormone Drugs 0.000 description 2
• 108010019677 lymphotactin Proteins 0.000 description 2
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
• 229960004961 mechlorethamine Drugs 0.000 description 2
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 2
• 229960001924 melphalan Drugs 0.000 description 2
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
• 229960004584 methylprednisolone Drugs 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 210000004688 microtubule Anatomy 0.000 description 2
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 208000037890 multiple organ injury Diseases 0.000 description 2
• 208000010805 mumps infectious disease Diseases 0.000 description 2
• 238000002703 mutagenesis Methods 0.000 description 2
• 231100000350 mutagenesis Toxicity 0.000 description 2
• RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 description 2
• 229960004866 mycophenolate mofetil Drugs 0.000 description 2
• 229960000951 mycophenolic acid Drugs 0.000 description 2
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 2
• 201000001119 neuropathy Diseases 0.000 description 2
• 230000007823 neuropathy Effects 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• 230000000683 nonmetastatic effect Effects 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• 201000005737 orchitis Diseases 0.000 description 2
• 201000008482 osteoarthritis Diseases 0.000 description 2
• 230000002611 ovarian Effects 0.000 description 2
• 210000001672 ovary Anatomy 0.000 description 2
• 229960001756 oxaliplatin Drugs 0.000 description 2
• DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
• 230000036407 pain Effects 0.000 description 2
• WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
• 230000007824 polyneuropathy Effects 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 229960002943 prednisolone sodium phosphate Drugs 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 206010063401 primary progressive multiple sclerosis Diseases 0.000 description 2
• 201000000742 primary sclerosing cholangitis Diseases 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 230000000750 progressive effect Effects 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 208000005069 pulmonary fibrosis Diseases 0.000 description 2
• 229950010131 puromycin Drugs 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 238000003259 recombinant expression Methods 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• 238000004007 reversed phase HPLC Methods 0.000 description 2
• HXCHCVDVKSCDHU-PJKCJEBCSA-N s-[(2r,3s,4s,6s)-6-[[(2r,3s,4s,5r,6r)-5-[(2s,4s,5s)-5-(ethylamino)-4-methoxyoxan-2-yl]oxy-4-hydroxy-6-[[(2s,5z,9r,13e)-9-hydroxy-12-(methoxycarbonylamino)-13-[2-(methyltrisulfanyl)ethylidene]-11-oxo-2-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-2-m Chemical compound C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-PJKCJEBCSA-N 0.000 description 2
• 229940095743 selective estrogen receptor modulator Drugs 0.000 description 2
• 239000000333 selective estrogen receptor modulator Substances 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 230000037439 somatic mutation Effects 0.000 description 2
• 201000005671 spondyloarthropathy Diseases 0.000 description 2
• PVYJZLYGTZKPJE-UHFFFAOYSA-N streptonigrin Chemical compound C=1C=C2C(=O)C(OC)=C(N)C(=O)C2=NC=1C(C=1N)=NC(C(O)=O)=C(C)C=1C1=CC=C(OC)C(OC)=C1O PVYJZLYGTZKPJE-UHFFFAOYSA-N 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• RCINICONZNJXQF-XAZOAEDWSA-N taxol® Chemical compound O([C@@H]1[C@@]2(CC(C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3(C21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-XAZOAEDWSA-N 0.000 description 2
• 229940063683 taxotere Drugs 0.000 description 2
• 229930101283 tetracycline Natural products 0.000 description 2
• 229960002180 tetracycline Drugs 0.000 description 2
• 235000019364 tetracycline Nutrition 0.000 description 2
• 150000003522 tetracyclines Chemical class 0.000 description 2
• 206010043554 thrombocytopenia Diseases 0.000 description 2
• 206010043778 thyroiditis Diseases 0.000 description 2
• 229960003087 tioguanine Drugs 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
• 108010087967 type I signal peptidase Proteins 0.000 description 2
• 230000005951 type IV hypersensitivity Effects 0.000 description 2
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
• 238000000108 ultra-filtration Methods 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 229910052720 vanadium Inorganic materials 0.000 description 2
• 229960003048 vinblastine Drugs 0.000 description 2
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 2
• 229960004355 vindesine Drugs 0.000 description 2
• UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• 239000011534 wash buffer Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
• BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
• YXTKHLHCVFUPPT-YYFJYKOTSA-N (2s)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1r,2r)-1,2-dimethanidylcyclohexane;5-fluoro-1h-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 description 1
• LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
• CGMTUJFWROPELF-YPAAEMCBSA-N (3E,5S)-5-[(2S)-butan-2-yl]-3-(1-hydroxyethylidene)pyrrolidine-2,4-dione Chemical compound CC[C@H](C)[C@@H]1NC(=O)\C(=C(/C)O)C1=O CGMTUJFWROPELF-YPAAEMCBSA-N 0.000 description 1
• OQANPHBRHBJGNZ-FYJGNVAPSA-N (3e)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=C\C1=N\NC1=CC=C(S(=O)(=O)NC=2N=CC=CC=2)C=C1 OQANPHBRHBJGNZ-FYJGNVAPSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• XRBSKUSTLXISAB-XVVDYKMHSA-N (5r,6r,7r,8r)-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxole-6-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H](CO)[C@@H]2C(O)=O)=C1 XRBSKUSTLXISAB-XVVDYKMHSA-N 0.000 description 1
• AESVUZLWRXEGEX-DKCAWCKPSA-N (7S,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione iron(3+) Chemical compound [Fe+3].COc1cccc2C(=O)c3c(O)c4C[C@@](O)(C[C@H](O[C@@H]5C[C@@H](N)[C@@H](O)[C@@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO AESVUZLWRXEGEX-DKCAWCKPSA-N 0.000 description 1
• INAUWOVKEZHHDM-PEDBPRJASA-N (7s,9s)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2r,4s,5s,6s)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.N1([C@H]2C[C@@H](O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCOCC1 INAUWOVKEZHHDM-PEDBPRJASA-N 0.000 description 1
• FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 description 1
• IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 description 1
• LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 description 1
• WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
• AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
• LJJFNFYPZOHRHM-UHFFFAOYSA-N 1-isocyano-2-methoxy-2-methylpropane Chemical compound COC(C)(C)C[N+]#[C-] LJJFNFYPZOHRHM-UHFFFAOYSA-N 0.000 description 1
• BTOTXLJHDSNXMW-POYBYMJQSA-N 2,3-dideoxyuridine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(=O)NC(=O)C=C1 BTOTXLJHDSNXMW-POYBYMJQSA-N 0.000 description 1
• BOMZMNZEXMAQQW-UHFFFAOYSA-N 2,5,11-trimethyl-6h-pyrido[4,3-b]carbazol-2-ium-9-ol;acetate Chemical compound CC([O-])=O.C[N+]1=CC=C2C(C)=C(NC=3C4=CC(O)=CC=3)C4=C(C)C2=C1 BOMZMNZEXMAQQW-UHFFFAOYSA-N 0.000 description 1
• AOTQGWFNFTVXNQ-UHFFFAOYSA-N 2-(1-adamantyl)acetic acid Chemical compound C1C(C2)CC3CC2CC1(CC(=O)O)C3 AOTQGWFNFTVXNQ-UHFFFAOYSA-N 0.000 description 1
• QCXJFISCRQIYID-IAEPZHFASA-N 2-amino-1-n-[(3s,6s,7r,10s,16s)-3-[(2s)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-9-n-[(3s,6s,7r,10s,16s)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propa Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N=C2C(C(=O)N[C@@H]3C(=O)N[C@H](C(N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]3C)=O)[C@@H](C)CC)=C(N)C(=O)C(C)=C2O2)C2=C(C)C=C1 QCXJFISCRQIYID-IAEPZHFASA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• CTRPRMNBTVRDFH-UHFFFAOYSA-N 2-n-methyl-1,3,5-triazine-2,4,6-triamine Chemical compound CNC1=NC(N)=NC(N)=N1 CTRPRMNBTVRDFH-UHFFFAOYSA-N 0.000 description 1
• AOPRXJXHLWYPQR-UHFFFAOYSA-N 2-phenoxyacetamide Chemical class NC(=O)COC1=CC=CC=C1 AOPRXJXHLWYPQR-UHFFFAOYSA-N 0.000 description 1
• 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
• NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
• PWMYMKOUNYTVQN-UHFFFAOYSA-N 3-(8,8-diethyl-2-aza-8-germaspiro[4.5]decan-2-yl)-n,n-dimethylpropan-1-amine Chemical compound C1C[Ge](CC)(CC)CCC11CN(CCCN(C)C)CC1 PWMYMKOUNYTVQN-UHFFFAOYSA-N 0.000 description 1
• QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
• CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
• SXXLKZCNJHJYFL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-5-ium-3-olate Chemical compound C1CNCC2=C1ONC2=O SXXLKZCNJHJYFL-UHFFFAOYSA-N 0.000 description 1
• CLPFFLWZZBQMAO-UHFFFAOYSA-N 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1N2C=NC=C2CCC1 CLPFFLWZZBQMAO-UHFFFAOYSA-N 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• 102100022464 5'-nucleotidase Human genes 0.000 description 1
• WBSMIPAMAXNXFS-UHFFFAOYSA-N 5-Nitro-2-(3-phenylpropylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCCC1=CC=CC=C1 WBSMIPAMAXNXFS-UHFFFAOYSA-N 0.000 description 1
• NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
• FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 101710142585 50S ribosomal protein 6, chloroplastic Proteins 0.000 description 1
• BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
• WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
• 229960005538 6-diazo-5-oxo-L-norleucine Drugs 0.000 description 1
• YCWQAMGASJSUIP-YFKPBYRVSA-N 6-diazo-5-oxo-L-norleucine Chemical compound OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-] YCWQAMGASJSUIP-YFKPBYRVSA-N 0.000 description 1
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
• ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
• FUXVKZWTXQUGMW-FQEVSTJZSA-N 9-Aminocamptothecin Chemical compound C1=CC(N)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 FUXVKZWTXQUGMW-FQEVSTJZSA-N 0.000 description 1
• HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 1
• 102100031901 A-kinase anchor protein 2 Human genes 0.000 description 1
• 230000005730 ADP ribosylation Effects 0.000 description 1
• 108010029988 AICDA (activation-induced cytidine deaminase) Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 102100028249 Acetyl-coenzyme A transporter 1 Human genes 0.000 description 1
• 206010056508 Acquired epidermolysis bullosa Diseases 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102100021886 Activin receptor type-2A Human genes 0.000 description 1
• 102100027647 Activin receptor type-2B Human genes 0.000 description 1
• 108010059616 Activins Proteins 0.000 description 1
• 206010001076 Acute sinusitis Diseases 0.000 description 1
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
• 102100036664 Adenosine deaminase Human genes 0.000 description 1
• 102100035990 Adenosine receptor A2a Human genes 0.000 description 1
• 206010062269 Adrenalitis Diseases 0.000 description 1
• 102100036601 Aggrecan core protein Human genes 0.000 description 1
• 108010067219 Aggrecans Proteins 0.000 description 1
• 201000010000 Agranulocytosis Diseases 0.000 description 1
• 108010012934 Albumin-Bound Paclitaxel Proteins 0.000 description 1
• 206010027654 Allergic conditions Diseases 0.000 description 1
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
• 201000004384 Alopecia Diseases 0.000 description 1
• 206010001766 Alopecia totalis Diseases 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
• 102100024581 Alpha-taxilin Human genes 0.000 description 1
• 208000024985 Alport syndrome Diseases 0.000 description 1
• CEIZFXOZIQNICU-UHFFFAOYSA-N Alternaria alternata Crofton-weed toxin Natural products CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
• 206010001881 Alveolar proteinosis Diseases 0.000 description 1
• 208000035939 Alveolitis allergic Diseases 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 102000000412 Annexin Human genes 0.000 description 1
• 108050008874 Annexin Proteins 0.000 description 1
• 102100031936 Anterior gradient protein 2 homolog Human genes 0.000 description 1
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 208000025494 Aortic disease Diseases 0.000 description 1
• 206010002961 Aplasia Diseases 0.000 description 1
• 208000032467 Aplastic anaemia Diseases 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 101100279540 Arabidopsis thaliana EIN2 gene Proteins 0.000 description 1
• 101100351711 Arabidopsis thaliana PEX14 gene Proteins 0.000 description 1
• 101100480809 Arabidopsis thaliana TCP10 gene Proteins 0.000 description 1
• 241000203069 Archaea Species 0.000 description 1
• 102100024003 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
• 102000014654 Aromatase Human genes 0.000 description 1
• 108010078554 Aromatase Proteins 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 206010003267 Arthritis reactive Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 206010003487 Aspergilloma Diseases 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• 206010003591 Ataxia Diseases 0.000 description 1
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 206010003805 Autism Diseases 0.000 description 1
• 208000020706 Autistic disease Diseases 0.000 description 1
• 206010071576 Autoimmune aplastic anaemia Diseases 0.000 description 1
• 206010064539 Autoimmune myocarditis Diseases 0.000 description 1
• 206010055128 Autoimmune neutropenia Diseases 0.000 description 1
• 208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 1
• 208000022106 Autoimmune polyendocrinopathy type 2 Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 1
• 102100035634 B-cell linker protein Human genes 0.000 description 1
• 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 108091012583 BCL2 Proteins 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 208000027496 Behcet disease Diseases 0.000 description 1
• 208000009137 Behcet syndrome Diseases 0.000 description 1
• VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100021257 Beta-secretase 1 Human genes 0.000 description 1
• 102100021277 Beta-secretase 2 Human genes 0.000 description 1
• DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
• 102100038495 Bile acid receptor Human genes 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 229940122361 Bisphosphonate Drugs 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 201000004569 Blindness Diseases 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• 102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 201000006474 Brain Ischemia Diseases 0.000 description 1
• 206010006448 Bronchiolitis Diseases 0.000 description 1
• 108010037003 Buserelin Proteins 0.000 description 1
• PYMDEDHDQYLBRT-DRIHCAFSSA-N Buserelin acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 PYMDEDHDQYLBRT-DRIHCAFSSA-N 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
• 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
• 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
• 101710149858 C-C chemokine receptor type 7 Proteins 0.000 description 1
• 102100036841 C-C motif chemokine 1 Human genes 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
• 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 102100034798 CCAAT/enhancer-binding protein beta Human genes 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 102100040531 CKLF-like MARVEL transmembrane domain-containing protein 2 Human genes 0.000 description 1
• 102100040527 CKLF-like MARVEL transmembrane domain-containing protein 3 Human genes 0.000 description 1
• 102100040529 CKLF-like MARVEL transmembrane domain-containing protein 4 Human genes 0.000 description 1
• 102100040855 CKLF-like MARVEL transmembrane domain-containing protein 7 Human genes 0.000 description 1
• 201000002829 CREST Syndrome Diseases 0.000 description 1
• 108091011896 CSF1 Proteins 0.000 description 1
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
• 229940045513 CTLA4 antagonist Drugs 0.000 description 1
• 108010061304 CXCR6 Receptors Proteins 0.000 description 1
• 102100024158 Cadherin-10 Human genes 0.000 description 1
• 102100024156 Cadherin-12 Human genes 0.000 description 1
• 102100024154 Cadherin-13 Human genes 0.000 description 1
• 102100022527 Cadherin-18 Human genes 0.000 description 1
• 102100022529 Cadherin-19 Human genes 0.000 description 1
• 102100029761 Cadherin-5 Human genes 0.000 description 1
• 102100025331 Cadherin-8 Human genes 0.000 description 1
• 102100025332 Cadherin-9 Human genes 0.000 description 1
• 208000004434 Calcinosis Diseases 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 101100293794 Canis lupus familiaris NME1 gene Proteins 0.000 description 1
• GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
• 102100033377 Carbohydrate sulfotransferase 15 Human genes 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 208000031229 Cardiomyopathies Diseases 0.000 description 1
• AOCCBINRVIKJHY-UHFFFAOYSA-N Carmofur Chemical compound CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O AOCCBINRVIKJHY-UHFFFAOYSA-N 0.000 description 1
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
• 102000004018 Caspase 6 Human genes 0.000 description 1
• 108090000425 Caspase 6 Proteins 0.000 description 1
• 102100035904 Caspase-1 Human genes 0.000 description 1
• 102100025597 Caspase-4 Human genes 0.000 description 1
• 108090000712 Cathepsin B Proteins 0.000 description 1
• 102000004225 Cathepsin B Human genes 0.000 description 1
• 102100021633 Cathepsin B Human genes 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
• 208000025985 Central nervous system inflammatory disease Diseases 0.000 description 1
• 206010008120 Cerebral ischaemia Diseases 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 102100031011 Chemerin-like receptor 1 Human genes 0.000 description 1
• 102000009410 Chemokine receptor Human genes 0.000 description 1
• 108050000299 Chemokine receptor Proteins 0.000 description 1
• 101100004180 Chironomus tentans BR3 gene Proteins 0.000 description 1
• JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 description 1
• MKQWTWSXVILIKJ-LXGUWJNJSA-N Chlorozotocin Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)NC(=O)N(N=O)CCCl MKQWTWSXVILIKJ-LXGUWJNJSA-N 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 1
• 108010038447 Chromogranin A Proteins 0.000 description 1
• 102100031186 Chromogranin-A Human genes 0.000 description 1
• 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
• 208000008818 Chronic Mucocutaneous Candidiasis Diseases 0.000 description 1
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
• 206010009137 Chronic sinusitis Diseases 0.000 description 1
• 102000003813 Cis-trans-isomerases Human genes 0.000 description 1
• 108090000175 Cis-trans-isomerases Proteins 0.000 description 1
• 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
• 108010044213 Class 5 Receptor-Like Protein Tyrosine Phosphatases Proteins 0.000 description 1
• 102100038423 Claudin-3 Human genes 0.000 description 1
• 108050007296 Claudin-7 Proteins 0.000 description 1
• 102100026735 Coagulation factor VIII Human genes 0.000 description 1
• 208000027932 Collagen disease Diseases 0.000 description 1
• 206010010619 Congenital rubella infection Diseases 0.000 description 1
• 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 229930188224 Cryptophycin Natural products 0.000 description 1
• 102000036364 Cullin Ring E3 Ligases Human genes 0.000 description 1
• 108091007045 Cullin Ring E3 Ligases Proteins 0.000 description 1
• 208000014311 Cushing syndrome Diseases 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 102100025176 Cyclin-A1 Human genes 0.000 description 1
• 102100025191 Cyclin-A2 Human genes 0.000 description 1
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
• 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
• 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
• 108010009356 Cyclin-Dependent Kinase Inhibitor p15 Proteins 0.000 description 1
• 102000009512 Cyclin-Dependent Kinase Inhibitor p15 Human genes 0.000 description 1
• 108010009367 Cyclin-Dependent Kinase Inhibitor p18 Proteins 0.000 description 1
• 102000009503 Cyclin-Dependent Kinase Inhibitor p18 Human genes 0.000 description 1
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
• 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
• 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 1
• 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 1
• 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
• 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 101150081028 Cysltr1 gene Proteins 0.000 description 1
• 206010011732 Cyst Diseases 0.000 description 1
• 102100038496 Cysteinyl leukotriene receptor 1 Human genes 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 102100031655 Cytochrome b5 Human genes 0.000 description 1
• 102100036952 Cytoplasmic protein NCK2 Human genes 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 description 1
• XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
• 239000012624 DNA alkylating agent Substances 0.000 description 1
• 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
• 101100481404 Danio rerio tie1 gene Proteins 0.000 description 1
• WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
• 206010011891 Deafness neurosensory Diseases 0.000 description 1
• 102100031817 Delta-type opioid receptor Human genes 0.000 description 1
• XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
• 208000001490 Dengue Diseases 0.000 description 1
• 206010012310 Dengue fever Diseases 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 108010002156 Depsipeptides Proteins 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• AUGQEEXBDZWUJY-ZLJUKNTDSA-N Diacetoxyscirpenol Chemical compound C([C@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)C)O2 AUGQEEXBDZWUJY-ZLJUKNTDSA-N 0.000 description 1
• AUGQEEXBDZWUJY-UHFFFAOYSA-N Diacetoxyscirpenol Natural products CC(=O)OCC12CCC(C)=CC1OC1C(O)C(OC(C)=O)C2(C)C11CO1 AUGQEEXBDZWUJY-UHFFFAOYSA-N 0.000 description 1
• 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
• 102100028571 Disabled homolog 2-interacting protein Human genes 0.000 description 1
• 102100024364 Disintegrin and metalloproteinase domain-containing protein 8 Human genes 0.000 description 1
• ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 description 1
• CYQFCXCEBYINGO-DLBZAZTESA-N Dronabinol Natural products C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@H]21 CYQFCXCEBYINGO-DLBZAZTESA-N 0.000 description 1
• 241000255601 Drosophila melanogaster Species 0.000 description 1
• 101100278839 Drosophila melanogaster sw gene Proteins 0.000 description 1
• 102100023332 Dual specificity mitogen-activated protein kinase kinase 7 Human genes 0.000 description 1
• 208000001708 Dupuytren contracture Diseases 0.000 description 1
• 102100040565 Dynein light chain 1, cytoplasmic Human genes 0.000 description 1
• 229930193152 Dynemicin Natural products 0.000 description 1
• 102100036254 E3 SUMO-protein ligase PIAS2 Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 208000005235 Echovirus Infections Diseases 0.000 description 1
• 208000017701 Endocrine disease Diseases 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• SAMRUMKYXPVKPA-VFKOLLTISA-N Enocitabine Chemical compound O=C1N=C(NC(=O)CCCCCCCCCCCCCCCCCCCCC)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 SAMRUMKYXPVKPA-VFKOLLTISA-N 0.000 description 1
• 241000305071 Enterobacterales Species 0.000 description 1
• 101710146739 Enterotoxin Proteins 0.000 description 1
• 206010014954 Eosinophilic fasciitis Diseases 0.000 description 1
• 206010064212 Eosinophilic oesophagitis Diseases 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 206010015084 Episcleritis Diseases 0.000 description 1
• OBMLHUPNRURLOK-XGRAFVIBSA-N Epitiostanol Chemical compound C1[C@@H]2S[C@@H]2C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 OBMLHUPNRURLOK-XGRAFVIBSA-N 0.000 description 1
• 206010015108 Epstein-Barr virus infection Diseases 0.000 description 1
• 206010015150 Erythema Diseases 0.000 description 1
• 206010015218 Erythema multiforme Diseases 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 101100409165 Escherichia coli (strain K12) prc gene Proteins 0.000 description 1
• 208000030644 Esophageal Motility disease Diseases 0.000 description 1
• 229930189413 Esperamicin Natural products 0.000 description 1
• 102100029951 Estrogen receptor beta Human genes 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
• 208000004332 Evans syndrome Diseases 0.000 description 1
• 102100026693 FAS-associated death domain protein Human genes 0.000 description 1
• 208000004929 Facial Paralysis Diseases 0.000 description 1
• 208000027445 Farmer Lung Diseases 0.000 description 1
• 208000028387 Felty syndrome Diseases 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 1
• 102100035323 Fibroblast growth factor 18 Human genes 0.000 description 1
• 102100024804 Fibroblast growth factor 22 Human genes 0.000 description 1
• 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
• 102100037680 Fibroblast growth factor 8 Human genes 0.000 description 1
• 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
• 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
• 208000001640 Fibromyalgia Diseases 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 206010016717 Fistula Diseases 0.000 description 1
• MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 1
• 206010016952 Food poisoning Diseases 0.000 description 1
• 208000019331 Foodborne disease Diseases 0.000 description 1
• 241000700662 Fowlpox virus Species 0.000 description 1
• 102000006471 Fucosyltransferases Human genes 0.000 description 1
• 230000037057 G1 phase arrest Effects 0.000 description 1
• 230000005526 G1 to G0 transition Effects 0.000 description 1
• 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
• 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 description 1
• 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 1
• 102000017700 GABRP Human genes 0.000 description 1
• 208000036495 Gastritis atrophic Diseases 0.000 description 1
• 208000018522 Gastrointestinal disease Diseases 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 208000007465 Giant cell arteritis Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
• 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
• 102000058058 Glucose Transporter Type 2 Human genes 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 102100033366 Glutathione hydrolase 1 proenzyme Human genes 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108700023372 Glycosyltransferases Proteins 0.000 description 1
• 102000051366 Glycosyltransferases Human genes 0.000 description 1
• 102000006771 Gonadotropins Human genes 0.000 description 1
• 108010086677 Gonadotropins Proteins 0.000 description 1
• 108010069236 Goserelin Proteins 0.000 description 1
• 206010018687 Granulocytopenia Diseases 0.000 description 1
• 206010018691 Granuloma Diseases 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
• 102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 108010067802 HLA-DR alpha-Chains Proteins 0.000 description 1
• 208000008899 Habitual abortion Diseases 0.000 description 1
• 206010018910 Haemolysis Diseases 0.000 description 1
• 101100508941 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) ppa gene Proteins 0.000 description 1
• 208000001204 Hashimoto Disease Diseases 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 208000018565 Hemochromatosis Diseases 0.000 description 1
• 208000032843 Hemorrhage Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 description 1
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 206010019755 Hepatitis chronic active Diseases 0.000 description 1
• 102100034676 Hepatocyte cell adhesion molecule Human genes 0.000 description 1
• 208000028523 Hereditary Complement Deficiency disease Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 206010062639 Herpes dermatitis Diseases 0.000 description 1
• 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 description 1
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
• 102000003964 Histone deacetylase Human genes 0.000 description 1
• 108090000353 Histone deacetylase Proteins 0.000 description 1
• 102100021454 Histone deacetylase 4 Human genes 0.000 description 1
• 102100021453 Histone deacetylase 5 Human genes 0.000 description 1
• 102100038719 Histone deacetylase 7 Human genes 0.000 description 1
• 102100038720 Histone deacetylase 9 Human genes 0.000 description 1
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
• 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 description 1
• 101000774738 Homo sapiens A-kinase anchor protein 2 Proteins 0.000 description 1
• 101000970954 Homo sapiens Activin receptor type-2A Proteins 0.000 description 1
• 101000937269 Homo sapiens Activin receptor type-2B Proteins 0.000 description 1
• 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
• 101000783751 Homo sapiens Adenosine receptor A2a Proteins 0.000 description 1
• 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
• 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 1
• 101000760787 Homo sapiens Alpha-taxilin Proteins 0.000 description 1
• 101000775021 Homo sapiens Anterior gradient protein 2 homolog Proteins 0.000 description 1
• 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 1
• 101000803266 Homo sapiens B-cell linker protein Proteins 0.000 description 1
• 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 description 1
• 101000894883 Homo sapiens Beta-secretase 2 Proteins 0.000 description 1
• 101000603876 Homo sapiens Bile acid receptor Proteins 0.000 description 1
• 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
• 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
• 101000945963 Homo sapiens CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000868215 Homo sapiens CD40 ligand Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000749427 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 2 Proteins 0.000 description 1
• 101000749433 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 3 Proteins 0.000 description 1
• 101000749431 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 4 Proteins 0.000 description 1
• 101000749308 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 7 Proteins 0.000 description 1
• 101000762229 Homo sapiens Cadherin-10 Proteins 0.000 description 1
• 101000762238 Homo sapiens Cadherin-12 Proteins 0.000 description 1
• 101000762243 Homo sapiens Cadherin-13 Proteins 0.000 description 1
• 101000899405 Homo sapiens Cadherin-18 Proteins 0.000 description 1
• 101000794587 Homo sapiens Cadherin-5 Proteins 0.000 description 1
• 101000935111 Homo sapiens Cadherin-7 Proteins 0.000 description 1
• 101000935095 Homo sapiens Cadherin-8 Proteins 0.000 description 1
• 101000935098 Homo sapiens Cadherin-9 Proteins 0.000 description 1
• 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 1
• 101000933112 Homo sapiens Caspase-4 Proteins 0.000 description 1
• 101000898449 Homo sapiens Cathepsin B Proteins 0.000 description 1
• 101000919756 Homo sapiens Chemerin-like receptor 1 Proteins 0.000 description 1
• 101000882908 Homo sapiens Claudin-3 Proteins 0.000 description 1
• 101000912652 Homo sapiens Claudin-7 Proteins 0.000 description 1
• 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
• 101000934314 Homo sapiens Cyclin-A1 Proteins 0.000 description 1
• 101000934320 Homo sapiens Cyclin-A2 Proteins 0.000 description 1
• 101000715946 Homo sapiens Cyclin-dependent kinase 3 Proteins 0.000 description 1
• 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 1
• 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 1
• 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
• 101000922386 Homo sapiens Cytochrome b5 Proteins 0.000 description 1
• 101001024712 Homo sapiens Cytoplasmic protein NCK2 Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101000992305 Homo sapiens Delta-type opioid receptor Proteins 0.000 description 1
• 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 1
• 101000915396 Homo sapiens Disabled homolog 2-interacting protein Proteins 0.000 description 1
• 101000832767 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 8 Proteins 0.000 description 1
• 101000624594 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 7 Proteins 0.000 description 1
• 101000966403 Homo sapiens Dynein light chain 1, cytoplasmic Proteins 0.000 description 1
• 101001074629 Homo sapiens E3 SUMO-protein ligase PIAS2 Proteins 0.000 description 1
• 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
• 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
• 101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 description 1
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 1
• 101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 description 1
• 101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 description 1
• 101001051971 Homo sapiens Fibroblast growth factor 22 Proteins 0.000 description 1
• 101001060267 Homo sapiens Fibroblast growth factor 5 Proteins 0.000 description 1
• 101001027382 Homo sapiens Fibroblast growth factor 8 Proteins 0.000 description 1
• 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 description 1
• 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 1
• 101000822394 Homo sapiens Gamma-aminobutyric acid receptor subunit pi Proteins 0.000 description 1
• 101000997558 Homo sapiens Glutathione hydrolase 1 proenzyme Proteins 0.000 description 1
• 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 1
• 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101000872875 Homo sapiens Hepatocyte cell adhesion molecule Proteins 0.000 description 1
• 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 description 1
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
• 101000899259 Homo sapiens Histone deacetylase 4 Proteins 0.000 description 1
• 101000899255 Homo sapiens Histone deacetylase 5 Proteins 0.000 description 1
• 101001032113 Homo sapiens Histone deacetylase 7 Proteins 0.000 description 1
• 101001032092 Homo sapiens Histone deacetylase 9 Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 1
• 101001044927 Homo sapiens Insulin-like growth factor-binding protein 3 Proteins 0.000 description 1
• 101000840582 Homo sapiens Insulin-like growth factor-binding protein 6 Proteins 0.000 description 1
• 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 1
• 101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 1
• 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 1
• 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 1
• 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
• 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 1
• 101001015006 Homo sapiens Integrin beta-4 Proteins 0.000 description 1
• 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
• 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
• 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
• 101000852965 Homo sapiens Interleukin-1 receptor-like 2 Proteins 0.000 description 1
• 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 1
• 101001003147 Homo sapiens Interleukin-11 receptor subunit alpha Proteins 0.000 description 1
• 101001003138 Homo sapiens Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
• 101001003135 Homo sapiens Interleukin-13 receptor subunit alpha-1 Proteins 0.000 description 1
• 101001003132 Homo sapiens Interleukin-13 receptor subunit alpha-2 Proteins 0.000 description 1
• 101001003140 Homo sapiens Interleukin-15 receptor subunit alpha Proteins 0.000 description 1
• 101001019598 Homo sapiens Interleukin-17 receptor A Proteins 0.000 description 1
• 101000998178 Homo sapiens Interleukin-17C Proteins 0.000 description 1
• 101000998151 Homo sapiens Interleukin-17F Proteins 0.000 description 1
• 101000961065 Homo sapiens Interleukin-18 receptor 1 Proteins 0.000 description 1
• 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 1
• 101000960946 Homo sapiens Interleukin-19 Proteins 0.000 description 1
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
• 101001010591 Homo sapiens Interleukin-20 Proteins 0.000 description 1
• 101001044893 Homo sapiens Interleukin-20 receptor subunit alpha Proteins 0.000 description 1
• 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 description 1
• 101001044883 Homo sapiens Interleukin-22 receptor subunit alpha-1 Proteins 0.000 description 1
• 101001044887 Homo sapiens Interleukin-22 receptor subunit alpha-2 Proteins 0.000 description 1
• 101000853009 Homo sapiens Interleukin-24 Proteins 0.000 description 1
• 101000998140 Homo sapiens Interleukin-36 alpha Proteins 0.000 description 1
• 101000998126 Homo sapiens Interleukin-36 beta Proteins 0.000 description 1
• 101000998122 Homo sapiens Interleukin-37 Proteins 0.000 description 1
• 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 1
• 101001055219 Homo sapiens Interleukin-9 receptor Proteins 0.000 description 1
• 101000605522 Homo sapiens Kallikrein-1 Proteins 0.000 description 1
• 101000605516 Homo sapiens Kallikrein-12 Proteins 0.000 description 1
• 101000605514 Homo sapiens Kallikrein-13 Proteins 0.000 description 1
• 101000605520 Homo sapiens Kallikrein-14 Proteins 0.000 description 1
• 101000605518 Homo sapiens Kallikrein-15 Proteins 0.000 description 1
• 101001091379 Homo sapiens Kallikrein-5 Proteins 0.000 description 1
• 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
• 101001091356 Homo sapiens Kallikrein-9 Proteins 0.000 description 1
• 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 1
• 101001046936 Homo sapiens Keratin, type II cytoskeletal 2 epidermal Proteins 0.000 description 1
• 101001046952 Homo sapiens Keratin, type II cytoskeletal 2 oral Proteins 0.000 description 1
• 101000934753 Homo sapiens Keratin, type II cytoskeletal 75 Proteins 0.000 description 1
• 101001139126 Homo sapiens Krueppel-like factor 6 Proteins 0.000 description 1
• 101001007417 Homo sapiens LEM domain-containing protein 2 Proteins 0.000 description 1
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
• 101001017969 Homo sapiens Leukotriene B4 receptor 2 Proteins 0.000 description 1
• 101000927946 Homo sapiens LisH domain-containing protein ARMC9 Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
• 101000739159 Homo sapiens Mammaglobin-A Proteins 0.000 description 1
• 101000739168 Homo sapiens Mammaglobin-B Proteins 0.000 description 1
• 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 1
• 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 description 1
• 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 description 1
• 101000976899 Homo sapiens Mitogen-activated protein kinase 15 Proteins 0.000 description 1
• 101001013159 Homo sapiens Myeloid leukemia factor 2 Proteins 0.000 description 1
• 101000961071 Homo sapiens NF-kappa-B inhibitor alpha Proteins 0.000 description 1
• 101000928278 Homo sapiens Natriuretic peptides B Proteins 0.000 description 1
• 101000995164 Homo sapiens Netrin-4 Proteins 0.000 description 1
• 101000979338 Homo sapiens Nuclear factor NF-kappa-B p100 subunit Proteins 0.000 description 1
• 101001109700 Homo sapiens Nuclear receptor subfamily 4 group A member 1 Proteins 0.000 description 1
• 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 description 1
• 101001109689 Homo sapiens Nuclear receptor subfamily 4 group A member 3 Proteins 0.000 description 1
• 101001109685 Homo sapiens Nuclear receptor subfamily 5 group A member 2 Proteins 0.000 description 1
• 101001109682 Homo sapiens Nuclear receptor subfamily 6 group A member 1 Proteins 0.000 description 1
• 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 description 1
• 101001098175 Homo sapiens P2X purinoceptor 7 Proteins 0.000 description 1
• 101000613565 Homo sapiens PRKC apoptosis WT1 regulator protein Proteins 0.000 description 1
• 101000595751 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Proteins 0.000 description 1
• 101001091365 Homo sapiens Plasma kallikrein Proteins 0.000 description 1
• 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 1
• 101001056707 Homo sapiens Proepiregulin Proteins 0.000 description 1
• 101000610543 Homo sapiens Prokineticin-2 Proteins 0.000 description 1
• 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 1
• 101001117314 Homo sapiens Prostaglandin D2 receptor 2 Proteins 0.000 description 1
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 1
• 101000605534 Homo sapiens Prostate-specific antigen Proteins 0.000 description 1
• 101000602015 Homo sapiens Protocadherin gamma-B4 Proteins 0.000 description 1
• 101001110313 Homo sapiens Ras-related C3 botulinum toxin substrate 2 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101001132698 Homo sapiens Retinoic acid receptor beta Proteins 0.000 description 1
• 101000716809 Homo sapiens Secretogranin-1 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000689224 Homo sapiens Src-like-adapter 2 Proteins 0.000 description 1
• 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 1
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
• 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 1
• 101000738335 Homo sapiens T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 description 1
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101100425948 Homo sapiens TNFRSF13C gene Proteins 0.000 description 1
• 101000800639 Homo sapiens Teneurin-1 Proteins 0.000 description 1
• 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 1
• 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 1
• 101000796134 Homo sapiens Thymidine phosphorylase Proteins 0.000 description 1
• 101000830560 Homo sapiens Toll-interacting protein Proteins 0.000 description 1
• 101000763537 Homo sapiens Toll-like receptor 10 Proteins 0.000 description 1
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
• 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 description 1
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 1
• 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 1
• 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 1
• 101000904152 Homo sapiens Transcription factor E2F1 Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 1
• 101000851892 Homo sapiens Tropomyosin beta chain Proteins 0.000 description 1
• 101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 description 1
• 101000764263 Homo sapiens Tumor necrosis factor ligand superfamily member 4 Proteins 0.000 description 1
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
• 101000679921 Homo sapiens Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 1
• 101000611185 Homo sapiens Tumor necrosis factor receptor superfamily member 5 Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• 101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 1
• 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
• 101000742579 Homo sapiens Vascular endothelial growth factor B Proteins 0.000 description 1
• 101000742596 Homo sapiens Vascular endothelial growth factor C Proteins 0.000 description 1
• 101000666856 Homo sapiens Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 1
• 101001059220 Homo sapiens Zinc finger protein Gfi-1 Proteins 0.000 description 1
• 241000701109 Human adenovirus 2 Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 101100273566 Humulus lupulus CCL10 gene Proteins 0.000 description 1
• 206010020524 Hydronephrosis Diseases 0.000 description 1
• 208000004454 Hyperalgesia Diseases 0.000 description 1
• 208000035154 Hyperesthesia Diseases 0.000 description 1
• 206010020631 Hypergammaglobulinaemia benign monoclonal Diseases 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• 206010020850 Hyperthyroidism Diseases 0.000 description 1
• 206010058359 Hypogonadism Diseases 0.000 description 1
• 208000000038 Hypoparathyroidism Diseases 0.000 description 1
• 206010021067 Hypopituitarism Diseases 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 108091058536 IL1F9 Proteins 0.000 description 1
• MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 description 1
• XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
• XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
• 208000016300 Idiopathic chronic eosinophilic pneumonia Diseases 0.000 description 1
• 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 1
• 101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 206010062717 Increased upper airway secretion Diseases 0.000 description 1
• 208000004575 Infectious Arthritis Diseases 0.000 description 1
• 102100026818 Inhibin beta E chain Human genes 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 1
• 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 1
• 102100029180 Insulin-like growth factor-binding protein 6 Human genes 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100025305 Integrin alpha-2 Human genes 0.000 description 1
• 102100032819 Integrin alpha-3 Human genes 0.000 description 1
• 102100032816 Integrin alpha-6 Human genes 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 102100022337 Integrin alpha-V Human genes 0.000 description 1
• 108010041012 Integrin alpha4 Proteins 0.000 description 1
• 108010040765 Integrin alphaV Proteins 0.000 description 1
• 102100032999 Integrin beta-3 Human genes 0.000 description 1
• 102100033000 Integrin beta-4 Human genes 0.000 description 1
• 102000008607 Integrin beta3 Human genes 0.000 description 1
• 108010020950 Integrin beta3 Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108700003107 Interleukin-1 Receptor-Like 1 Proteins 0.000 description 1
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
• 102100036706 Interleukin-1 receptor-like 1 Human genes 0.000 description 1
• 102100036697 Interleukin-1 receptor-like 2 Human genes 0.000 description 1
• 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 1
• 102100020787 Interleukin-11 receptor subunit alpha Human genes 0.000 description 1
• 102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
• 108010089995 Interleukin-13 Receptor alpha1 Subunit Proteins 0.000 description 1
• 102000008035 Interleukin-13 Receptor alpha1 Subunit Human genes 0.000 description 1
• 108010085418 Interleukin-13 Receptor alpha2 Subunit Proteins 0.000 description 1
• 102000007482 Interleukin-13 Receptor alpha2 Subunit Human genes 0.000 description 1
• 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 1
• 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102100035018 Interleukin-17 receptor A Human genes 0.000 description 1
• 102100033105 Interleukin-17C Human genes 0.000 description 1
• 102100033454 Interleukin-17F Human genes 0.000 description 1
• 102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 1
• 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 1
• 108050009288 Interleukin-19 Proteins 0.000 description 1
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
• 102100022706 Interleukin-20 receptor subunit alpha Human genes 0.000 description 1
• 108010017411 Interleukin-21 Receptors Proteins 0.000 description 1
• 102100030699 Interleukin-21 receptor Human genes 0.000 description 1
• 102100030703 Interleukin-22 Human genes 0.000 description 1
• 102100022723 Interleukin-22 receptor subunit alpha-1 Human genes 0.000 description 1
• 102100022703 Interleukin-22 receptor subunit alpha-2 Human genes 0.000 description 1
• 102000013264 Interleukin-23 Human genes 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 102100036671 Interleukin-24 Human genes 0.000 description 1
• 102100033474 Interleukin-36 alpha Human genes 0.000 description 1
• 102100033498 Interleukin-36 beta Human genes 0.000 description 1
• 102100033503 Interleukin-36 gamma Human genes 0.000 description 1
• 102100033502 Interleukin-37 Human genes 0.000 description 1
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
• 208000000209 Isaacs syndrome Diseases 0.000 description 1
• UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
• 208000012528 Juvenile dermatomyositis Diseases 0.000 description 1
• 102100038318 Kallikrein-12 Human genes 0.000 description 1
• 102100038315 Kallikrein-13 Human genes 0.000 description 1
• 102100038298 Kallikrein-14 Human genes 0.000 description 1
• 102100038301 Kallikrein-15 Human genes 0.000 description 1
• 102100034872 Kallikrein-4 Human genes 0.000 description 1
• 102100034868 Kallikrein-5 Human genes 0.000 description 1
• 102100034866 Kallikrein-6 Human genes 0.000 description 1
• 102100034876 Kallikrein-9 Human genes 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• 102100022854 Keratin, type II cytoskeletal 2 epidermal Human genes 0.000 description 1
• 102100022926 Keratin, type II cytoskeletal 2 oral Human genes 0.000 description 1
• 102100025367 Keratin, type II cytoskeletal 75 Human genes 0.000 description 1
• 108010066302 Keratin-19 Proteins 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 208000001126 Keratosis Diseases 0.000 description 1
• 102100020679 Krueppel-like factor 6 Human genes 0.000 description 1
• 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 239000002136 L01XE07 - Lapatinib Substances 0.000 description 1
• 102100028291 LEM domain-containing protein 2 Human genes 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 235000019687 Lamb Nutrition 0.000 description 1
• 201000010743 Lambert-Eaton myasthenic syndrome Diseases 0.000 description 1
• 102100038269 Large neutral amino acids transporter small subunit 3 Human genes 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
• 102100033375 Leukotriene B4 receptor 2 Human genes 0.000 description 1
• 208000012309 Linear IgA disease Diseases 0.000 description 1
• 208000004883 Lipoid Nephrosis Diseases 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 102100036882 LisH domain-containing protein ARMC9 Human genes 0.000 description 1
• MEPSBMMZQBMKHM-UHFFFAOYSA-N Lomatiol Natural products CC(=C/CC1=C(O)C(=O)c2ccccc2C1=O)CO MEPSBMMZQBMKHM-UHFFFAOYSA-N 0.000 description 1
• GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
• 101710172064 Low-density lipoprotein receptor-related protein Proteins 0.000 description 1
• 102100040705 Low-density lipoprotein receptor-related protein 8 Human genes 0.000 description 1
• 208000019693 Lung disease Diseases 0.000 description 1
• 206010025102 Lung infiltration Diseases 0.000 description 1
• 239000006137 Luria-Bertani broth Substances 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 101150053046 MYD88 gene Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 108010031030 Mammaglobin A Proteins 0.000 description 1
• 108010031029 Mammaglobin B Proteins 0.000 description 1
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
• 229930126263 Maytansine Natural products 0.000 description 1
• 102100026712 Metalloreductase STEAP1 Human genes 0.000 description 1
• 102100026711 Metalloreductase STEAP2 Human genes 0.000 description 1
• 108010092801 Midkine Proteins 0.000 description 1
• 208000019695 Migraine disease Diseases 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
• 101710151803 Mitochondrial intermediate peptidase 2 Proteins 0.000 description 1
• 102100023483 Mitogen-activated protein kinase 15 Human genes 0.000 description 1
• 229930192392 Mitomycin Natural products 0.000 description 1
• 206010060880 Monoclonal gammopathy Diseases 0.000 description 1
• 102000013967 Monokines Human genes 0.000 description 1
• 108010050619 Monokines Proteins 0.000 description 1
• 206010028080 Mucocutaneous candidiasis Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100219997 Mus musculus Ccr1 gene Proteins 0.000 description 1
• 101100027996 Mus musculus Omg gene Proteins 0.000 description 1
• 101100481406 Mus musculus Tie1 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• 206010028372 Muscular weakness Diseases 0.000 description 1
• 206010028424 Myasthenic syndrome Diseases 0.000 description 1
• 102100026784 Myelin proteolipid protein Human genes 0.000 description 1
• 101710094913 Myelin proteolipid protein Proteins 0.000 description 1
• 102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 description 1
• 102100029687 Myeloid leukemia factor 2 Human genes 0.000 description 1
• 102100031789 Myeloid-derived growth factor Human genes 0.000 description 1
• 206010028594 Myocardial fibrosis Diseases 0.000 description 1
• 208000009525 Myocarditis Diseases 0.000 description 1
• 201000009623 Myopathy Diseases 0.000 description 1
• 201000002481 Myositis Diseases 0.000 description 1
• 206010028665 Myxoedema Diseases 0.000 description 1
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
• 102100039337 NF-kappa-B inhibitor alpha Human genes 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
• 102100036836 Natriuretic peptides B Human genes 0.000 description 1
• 206010051606 Necrotising colitis Diseases 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 108010043296 Neurocan Proteins 0.000 description 1
• 102100030466 Neurocan core protein Human genes 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 206010072359 Neuromyotonia Diseases 0.000 description 1
• 108090000772 Neuropilin-1 Proteins 0.000 description 1
• 108090000770 Neuropilin-2 Proteins 0.000 description 1
• 101100407828 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-3 gene Proteins 0.000 description 1
• SYNHCENRCUAUNM-UHFFFAOYSA-N Nitrogen mustard N-oxide hydrochloride Chemical compound Cl.ClCC[N+]([O-])(C)CCCl SYNHCENRCUAUNM-UHFFFAOYSA-N 0.000 description 1
• 108010077641 Nogo Proteins Proteins 0.000 description 1
• 102000010410 Nogo Proteins Human genes 0.000 description 1
• 102100023059 Nuclear factor NF-kappa-B p100 subunit Human genes 0.000 description 1
• 102100022679 Nuclear receptor subfamily 4 group A member 1 Human genes 0.000 description 1
• 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 description 1
• 102100022673 Nuclear receptor subfamily 4 group A member 3 Human genes 0.000 description 1
• 102100022669 Nuclear receptor subfamily 5 group A member 2 Human genes 0.000 description 1
• 102100022670 Nuclear receptor subfamily 6 group A member 1 Human genes 0.000 description 1
• 102100023252 Nucleoside diphosphate kinase A Human genes 0.000 description 1
• 108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
• 108010042215 OX40 Ligand Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 229930187135 Olivomycin Natural products 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 102100021079 Ornithine decarboxylase Human genes 0.000 description 1
• 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
• 208000005141 Otitis Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 108010087367 P-glycoprotein 2 Proteins 0.000 description 1
• 102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
• 102100040853 PRKC apoptosis WT1 regulator protein Human genes 0.000 description 1
• 101150084398 PTAFR gene Proteins 0.000 description 1
• 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 206010033645 Pancreatitis Diseases 0.000 description 1
• 206010033661 Pancytopenia Diseases 0.000 description 1
• 241001057811 Paracoccus <mealybug> Species 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 102000003982 Parathyroid hormone Human genes 0.000 description 1
• 108090000445 Parathyroid hormone Proteins 0.000 description 1
• UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
• 208000008071 Parvoviridae Infections Diseases 0.000 description 1
• 206010057343 Parvovirus infection Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 108010087702 Penicillinase Proteins 0.000 description 1
• 108010057150 Peplomycin Proteins 0.000 description 1
• 208000008469 Peptic Ulcer Diseases 0.000 description 1
• 102000015731 Peptide Hormones Human genes 0.000 description 1
• 108010038988 Peptide Hormones Proteins 0.000 description 1
• 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 description 1
• 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 1
• 102100036052 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human genes 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 108090000316 Pitrilysin Proteins 0.000 description 1
• 108010003044 Placental Lactogen Proteins 0.000 description 1
• 239000000381 Placental Lactogen Substances 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 102100034869 Plasma kallikrein Human genes 0.000 description 1
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
• 102100030304 Platelet factor 4 Human genes 0.000 description 1
• 108700023400 Platelet-activating factor receptors Proteins 0.000 description 1
• 102100037596 Platelet-derived growth factor subunit A Human genes 0.000 description 1
• 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 206010035742 Pneumonitis Diseases 0.000 description 1
• 206010036030 Polyarthritis Diseases 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 208000026378 Polyglandular endocrine disease Diseases 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 208000037062 Polyps Diseases 0.000 description 1
• HRHKSTOGXBBQCB-UHFFFAOYSA-N Porfiromycine Chemical compound O=C1C(N)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)C3N(C)C3CN12 HRHKSTOGXBBQCB-UHFFFAOYSA-N 0.000 description 1
• 206010036242 Post vaccination syndrome Diseases 0.000 description 1
• 206010036297 Postpartum hypopituitarism Diseases 0.000 description 1
• 206010036631 Presenile dementia Diseases 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 206010036697 Primary hypothyroidism Diseases 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
• 241000677647 Proba Species 0.000 description 1
• 102100025498 Proepiregulin Human genes 0.000 description 1
• 108010076181 Proinsulin Proteins 0.000 description 1
• 102100040125 Prokineticin-2 Human genes 0.000 description 1
• 102000003946 Prolactin Human genes 0.000 description 1
• 108010057464 Prolactin Proteins 0.000 description 1
• 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
• KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
• 102100024218 Prostaglandin D2 receptor 2 Human genes 0.000 description 1
• 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
• 101710127332 Protease I Proteins 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 101800004937 Protein C Proteins 0.000 description 1
• 102000017975 Protein C Human genes 0.000 description 1
• 108010001267 Protein Subunits Proteins 0.000 description 1
• 102000002067 Protein Subunits Human genes 0.000 description 1
• 102100024924 Protein kinase C alpha type Human genes 0.000 description 1
• 101710109947 Protein kinase C alpha type Proteins 0.000 description 1
• 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 description 1
• 102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 108010019674 Proto-Oncogene Proteins c-sis Proteins 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
• 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 1
• 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 1
• 206010037575 Pustular psoriasis Diseases 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• AHHFEZNOXOZZQA-ZEBDFXRSSA-N Ranimustine Chemical compound CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O AHHFEZNOXOZZQA-ZEBDFXRSSA-N 0.000 description 1
• 102100022129 Ras-related C3 botulinum toxin substrate 2 Human genes 0.000 description 1
• 208000003782 Raynaud disease Diseases 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
• 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
• 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 1
• 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 1
• 102100028508 Receptor-type tyrosine-protein phosphatase zeta Human genes 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 208000021329 Refractory celiac disease Diseases 0.000 description 1
• 108090000103 Relaxin Proteins 0.000 description 1
• 102000003743 Relaxin Human genes 0.000 description 1
• 102100033909 Retinoic acid receptor beta Human genes 0.000 description 1
• OWPCHSCAPHNHAV-UHFFFAOYSA-N Rhizoxin Natural products C1C(O)C2(C)OC2C=CC(C)C(OC(=O)C2)CC2CC2OC2C(=O)OC1C(C)C(OC)C(C)=CC=CC(C)=CC1=COC(C)=N1 OWPCHSCAPHNHAV-UHFFFAOYSA-N 0.000 description 1
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• CIEYTVIYYGTCCI-UHFFFAOYSA-N SJ000286565 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1 CIEYTVIYYGTCCI-UHFFFAOYSA-N 0.000 description 1
• 108091006299 SLC2A2 Proteins 0.000 description 1
• 108091006570 SLC33A1 Proteins 0.000 description 1
• 108091006993 SLC43A1 Proteins 0.000 description 1
• 108010011005 STAT6 Transcription Factor Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 101800001700 Saposin-D Proteins 0.000 description 1
• 229920002305 Schizophyllan Polymers 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 102100020867 Secretogranin-1 Human genes 0.000 description 1
• 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 1
• 229920005654 Sephadex Polymers 0.000 description 1
• 239000012507 Sephadex™ Substances 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 description 1
• 102100030758 Sex hormone-binding globulin Human genes 0.000 description 1
• 201000009895 Sheehan syndrome Diseases 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 102100023980 Signal transducer and activator of transcription 6 Human genes 0.000 description 1
• 201000010001 Silicosis Diseases 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 102100022433 Single-stranded DNA cytosine deaminase Human genes 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 102100024510 Src-like-adapter 2 Human genes 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 108010048349 Steroidogenic Factor 1 Proteins 0.000 description 1
• 102100029856 Steroidogenic factor 1 Human genes 0.000 description 1
• 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
• 108010023197 Streptokinase Proteins 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 206010042742 Sympathetic ophthalmia Diseases 0.000 description 1
• BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 description 1
• 102100036840 T-box transcription factor TBX21 Human genes 0.000 description 1
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
• 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 1
• 102100037906 T-cell surface glycoprotein CD3 zeta chain Human genes 0.000 description 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 102000004399 TNF receptor-associated factor 3 Human genes 0.000 description 1
• 108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 1
• 102000003715 TNF receptor-associated factor 4 Human genes 0.000 description 1
• 108090000008 TNF receptor-associated factor 4 Proteins 0.000 description 1
• 102000003718 TNF receptor-associated factor 5 Human genes 0.000 description 1
• 108090000001 TNF receptor-associated factor 5 Proteins 0.000 description 1
• 102000003714 TNF receptor-associated factor 6 Human genes 0.000 description 1
• 108090000009 TNF receptor-associated factor 6 Proteins 0.000 description 1
• 102000003623 TRPC6 Human genes 0.000 description 1
• 241001116500 Taxus Species 0.000 description 1
• 241001116498 Taxus baccata Species 0.000 description 1
• 206010043189 Telangiectasia Diseases 0.000 description 1
• 102100033213 Teneurin-1 Human genes 0.000 description 1
• CGMTUJFWROPELF-UHFFFAOYSA-N Tenuazonic acid Natural products CCC(C)C1NC(=O)C(=C(C)/O)C1=O CGMTUJFWROPELF-UHFFFAOYSA-N 0.000 description 1
• 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
• 102100034195 Thrombopoietin Human genes 0.000 description 1
• 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 description 1
• 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 1
• 102100031372 Thymidine phosphorylase Human genes 0.000 description 1
• 206010043781 Thyroiditis chronic Diseases 0.000 description 1
• 206010043784 Thyroiditis subacute Diseases 0.000 description 1
• 235000011941 Tilia x europaea Nutrition 0.000 description 1
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
• 102100024652 Toll-interacting protein Human genes 0.000 description 1
• 102000002689 Toll-like receptor Human genes 0.000 description 1
• 108020000411 Toll-like receptor Proteins 0.000 description 1
• 102100027009 Toll-like receptor 10 Human genes 0.000 description 1
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
• 102100039387 Toll-like receptor 6 Human genes 0.000 description 1
• 102100039390 Toll-like receptor 7 Human genes 0.000 description 1
• 102100033110 Toll-like receptor 8 Human genes 0.000 description 1
• 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
• 239000000317 Topoisomerase II Inhibitor Substances 0.000 description 1
• IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 description 1
• 206010044223 Toxic epidermal necrolysis Diseases 0.000 description 1
• 231100000087 Toxic epidermal necrolysis Toxicity 0.000 description 1
• 206010044248 Toxic shock syndrome Diseases 0.000 description 1
• 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
• 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102100024026 Transcription factor E2F1 Human genes 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 108010033576 Transferrin Receptors Proteins 0.000 description 1
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
• 102400001320 Transforming growth factor alpha Human genes 0.000 description 1
• 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
• 208000003441 Transfusion reaction Diseases 0.000 description 1
• 108050001421 Transient receptor potential channel, canonical 6 Proteins 0.000 description 1
• 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
• FYAMXEPQQLNQDM-UHFFFAOYSA-N Tris(1-aziridinyl)phosphine oxide Chemical compound C1CN1P(N1CC1)(=O)N1CC1 FYAMXEPQQLNQDM-UHFFFAOYSA-N 0.000 description 1
• 102100036471 Tropomyosin beta chain Human genes 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 description 1
• 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 1
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 1
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
• 102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 1
• 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 1
• 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
• 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 1
• VGQOVCHZGQWAOI-UHFFFAOYSA-N UNPD55612 Natural products N1C(O)C2CC(C=CC(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-UHFFFAOYSA-N 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
• 244000000188 Vaccinium ovalifolium Species 0.000 description 1
• 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 1
• 108010073919 Vascular Endothelial Growth Factor D Proteins 0.000 description 1
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 1
• 102100038217 Vascular endothelial growth factor B Human genes 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 206010047124 Vasculitis necrotising Diseases 0.000 description 1
• 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
• 241000863480 Vinca Species 0.000 description 1
• 229940122803 Vinca alkaloid Drugs 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 206010047642 Vitiligo Diseases 0.000 description 1
• 241000863000 Vitreoscilla Species 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 238000002441 X-ray diffraction Methods 0.000 description 1
• VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
• 102100029004 Zinc finger protein Gfi-1 Human genes 0.000 description 1
• PVNFMCBFDPTNQI-UIBOPQHZSA-N [(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] acetate [(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 3-methylbutanoate [(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-methylpropanoate [(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] propanoate Chemical compound CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(C)=O)[C@]2(C)OC2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2.CCC(=O)O[C@H]1CC(=O)N(C)c2cc(C\C(C)=C\C=C\[C@@H](OC)[C@@]3(O)C[C@H](OC(=O)N3)[C@@H](C)C3O[C@@]13C)cc(OC)c2Cl.CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)OC2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2.CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)CC(C)C)[C@]2(C)OC2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2 PVNFMCBFDPTNQI-UIBOPQHZSA-N 0.000 description 1
• SPJCRMJCFSJKDE-ZWBUGVOYSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)C(=O)CC1=CC=C(N(CCCl)CCCl)C=C1 SPJCRMJCFSJKDE-ZWBUGVOYSA-N 0.000 description 1
• XZSRRNFBEIOBDA-CFNBKWCHSA-N [2-[(2s,4s)-4-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1h-tetracen-2-yl]-2-oxoethyl] 2,2-diethoxyacetate Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)C(OCC)OCC)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 XZSRRNFBEIOBDA-CFNBKWCHSA-N 0.000 description 1
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
• 108010023617 abarelix Proteins 0.000 description 1
• AIWRTTMUVOZGPW-HSPKUQOVSA-N abarelix Chemical compound C([C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 AIWRTTMUVOZGPW-HSPKUQOVSA-N 0.000 description 1
• 229960002184 abarelix Drugs 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 229940028652 abraxane Drugs 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 229960001138 acetylsalicylic acid Drugs 0.000 description 1
• 229930183665 actinomycin Natural products 0.000 description 1
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000488 activin Substances 0.000 description 1
• 229940037127 actonel Drugs 0.000 description 1
• 208000037855 acute anterior uveitis Diseases 0.000 description 1
• 208000026816 acute arthritis Diseases 0.000 description 1
• 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 108010035879 albumin-bilirubin complex Proteins 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229940062527 alendronate Drugs 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
• 150000008052 alkyl sulfonates Chemical class 0.000 description 1
• 229940100198 alkylating agent Drugs 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
• 208000002029 allergic contact dermatitis Diseases 0.000 description 1
• 201000010435 allergic urticaria Diseases 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 208000004631 alopecia areata Diseases 0.000 description 1
• 108090000185 alpha-Synuclein Proteins 0.000 description 1
• 239000004178 amaranth Substances 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 125000003368 amide group Chemical group 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 229940126574 aminoglycoside antibiotic Drugs 0.000 description 1
• 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
• 229960002749 aminolevulinic acid Drugs 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• 229960000836 amitriptyline Drugs 0.000 description 1
• 229960001220 amsacrine Drugs 0.000 description 1
• XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 229940035676 analgesics Drugs 0.000 description 1
• 239000012491 analyte Substances 0.000 description 1
• 229960002932 anastrozole Drugs 0.000 description 1
• BBDAGFIXKZCXAH-CCXZUQQUSA-N ancitabine Chemical compound N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 BBDAGFIXKZCXAH-CCXZUQQUSA-N 0.000 description 1
• 229950000242 ancitabine Drugs 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 229940030486 androgens Drugs 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003957 anion exchange resin Substances 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• VGQOVCHZGQWAOI-HYUHUPJXSA-N anthramycin Chemical compound N1[C@@H](O)[C@@H]2CC(\C=C\C(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-HYUHUPJXSA-N 0.000 description 1
• 230000002280 anti-androgenic effect Effects 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000003474 anti-emetic effect Effects 0.000 description 1
• 229940046836 anti-estrogen Drugs 0.000 description 1
• 230000001833 anti-estrogenic effect Effects 0.000 description 1
• 229940124599 anti-inflammatory drug Drugs 0.000 description 1
• 230000000781 anti-lymphocytic effect Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000000469 anti-sperm effect Effects 0.000 description 1
• 239000000051 antiandrogen Substances 0.000 description 1
• 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
• 238000011091 antibody purification Methods 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 238000011319 anticancer therapy Methods 0.000 description 1
• 238000011394 anticancer treatment Methods 0.000 description 1
• 229940125681 anticonvulsant agent Drugs 0.000 description 1
• 239000001961 anticonvulsive agent Substances 0.000 description 1
• 239000002111 antiemetic agent Substances 0.000 description 1
• 230000009831 antigen interaction Effects 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 229940045687 antimetabolites folic acid analogs Drugs 0.000 description 1
• 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
• 229940041181 antineoplastic drug Drugs 0.000 description 1
• 239000003418 antiprogestin Substances 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 150000008209 arabinosides Chemical class 0.000 description 1
• 229940078010 arimidex Drugs 0.000 description 1
• 229940087620 aromasin Drugs 0.000 description 1
• 239000003886 aromatase inhibitor Substances 0.000 description 1
• 229940046844 aromatase inhibitors Drugs 0.000 description 1
• 230000006793 arrhythmia Effects 0.000 description 1
• 206010003119 arrhythmia Diseases 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 206010003230 arteritis Diseases 0.000 description 1
• 201000009361 ascariasis Diseases 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 230000001977 ataxic effect Effects 0.000 description 1
• 230000003143 atherosclerotic effect Effects 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 208000027625 autoimmune inner ear disease Diseases 0.000 description 1
• 201000009771 autoimmune polyendocrine syndrome type 1 Diseases 0.000 description 1
• 201000009780 autoimmune polyendocrine syndrome type 2 Diseases 0.000 description 1
• 208000010928 autoimmune thyroid disease Diseases 0.000 description 1
• 201000004982 autoimmune uveitis Diseases 0.000 description 1
• 229960002756 azacitidine Drugs 0.000 description 1
• 229940022777 azasan Drugs 0.000 description 1
• 229950011321 azaserine Drugs 0.000 description 1
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 229960002537 betamethasone Drugs 0.000 description 1
• UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
• QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
• 229960000997 bicalutamide Drugs 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 229950008548 bisantrene Drugs 0.000 description 1
• 150000004663 bisphosphonates Chemical class 0.000 description 1
• 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
• 201000000053 blastoma Diseases 0.000 description 1
• 208000034158 bleeding Diseases 0.000 description 1
• 230000000740 bleeding effect Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 210000000133 brain stem Anatomy 0.000 description 1
• OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
• 229960002802 bromocriptine Drugs 0.000 description 1
• 206010006451 bronchitis Diseases 0.000 description 1
• 229960005520 bryostatin Drugs 0.000 description 1
• MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 description 1
• MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 description 1
• 229960005064 buserelin acetate Drugs 0.000 description 1
• 229960002092 busulfan Drugs 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 108700002839 cactinomycin Proteins 0.000 description 1
• 229950009908 cactinomycin Drugs 0.000 description 1
• 230000002308 calcification Effects 0.000 description 1
• 239000004301 calcium benzoate Substances 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 229930195731 calicheamicin Natural products 0.000 description 1
• VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
• 229940127093 camptothecin Drugs 0.000 description 1
• 239000003560 cancer drug Substances 0.000 description 1
• 230000005907 cancer growth Effects 0.000 description 1
• 229960004117 capecitabine Drugs 0.000 description 1
• 235000017663 capsaicin Nutrition 0.000 description 1
• 229960002504 capsaicin Drugs 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 229960004562 carboplatin Drugs 0.000 description 1
• YAYRGNWWLMLWJE-UHFFFAOYSA-L carboplatin Chemical compound O=C1O[Pt](N)(N)OC(=O)C11CCC1 YAYRGNWWLMLWJE-UHFFFAOYSA-L 0.000 description 1
• XREUEWVEMYWFFA-CSKJXFQVSA-N carminomycin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XREUEWVEMYWFFA-CSKJXFQVSA-N 0.000 description 1
• 229930188550 carminomycin Natural products 0.000 description 1
• XREUEWVEMYWFFA-UHFFFAOYSA-N carminomycin I Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XREUEWVEMYWFFA-UHFFFAOYSA-N 0.000 description 1
• 229960003261 carmofur Drugs 0.000 description 1
• 229960005243 carmustine Drugs 0.000 description 1
• 229950001725 carubicin Drugs 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 230000006369 cell cycle progression Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 229940107810 cellcept Drugs 0.000 description 1
• 208000010353 central nervous system vasculitis Diseases 0.000 description 1
• 208000025434 cerebellar degeneration Diseases 0.000 description 1
• 206010008118 cerebral infarction Diseases 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• HJWLJNBZVZDLAQ-HAQNSBGRSA-N chembl2103874 Chemical compound C1C[C@@H](CS(=O)(=O)NC)CC[C@@H]1N(C)C1=NC=NC2=C1C=CN2 HJWLJNBZVZDLAQ-HAQNSBGRSA-N 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 239000012829 chemotherapy agent Substances 0.000 description 1
• 201000010415 childhood type dermatomyositis Diseases 0.000 description 1
• 229960003677 chloroquine Drugs 0.000 description 1
• WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
• 229960001480 chlorozotocin Drugs 0.000 description 1
• 208000012601 choreatic disease Diseases 0.000 description 1
• 201000004709 chorioretinitis Diseases 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 201000009323 chronic eosinophilic pneumonia Diseases 0.000 description 1
• 208000030949 chronic idiopathic urticaria Diseases 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
• 206010072757 chronic spontaneous urticaria Diseases 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 229960002286 clodronic acid Drugs 0.000 description 1
• HJKBJIYDJLVSAO-UHFFFAOYSA-L clodronic acid disodium salt Chemical compound [Na+].[Na+].OP([O-])(=O)C(Cl)(Cl)P(O)([O-])=O HJKBJIYDJLVSAO-UHFFFAOYSA-L 0.000 description 1
• 229960001338 colchicine Drugs 0.000 description 1
• 208000008609 collagenous colitis Diseases 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000006957 competitive inhibition Effects 0.000 description 1
• 239000005289 controlled pore glass Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 208000029078 coronary artery disease Diseases 0.000 description 1
• ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
• COFJBSXICYYSKG-OAUVCNBTSA-N cph2u7dndy Chemical compound OS(O)(=O)=O.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 COFJBSXICYYSKG-OAUVCNBTSA-N 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 229940064774 cuprimine Drugs 0.000 description 1
• 208000004921 cutaneous lupus erythematosus Diseases 0.000 description 1
• HJZLEGIHUQOJBA-UHFFFAOYSA-N cyclohexane propionic acid Chemical compound OC(=O)CCC1CCCCC1 HJZLEGIHUQOJBA-UHFFFAOYSA-N 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
• 229940099500 cystamine Drugs 0.000 description 1
• 229960000684 cytarabine Drugs 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 229960000640 dactinomycin Drugs 0.000 description 1
• POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 1
• 229960000766 danazol Drugs 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000017858 demethylation Effects 0.000 description 1
• 238000010520 demethylation reaction Methods 0.000 description 1
• 208000025729 dengue disease Diseases 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• 229950003913 detorubicin Drugs 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 201000010064 diabetes insipidus Diseases 0.000 description 1
• 208000033679 diabetic kidney disease Diseases 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 229910003460 diamond Inorganic materials 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• WVYXNIXAMZOZFK-UHFFFAOYSA-N diaziquone Chemical compound O=C1C(NC(=O)OCC)=C(N2CC2)C(=O)C(NC(=O)OCC)=C1N1CC1 WVYXNIXAMZOZFK-UHFFFAOYSA-N 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 208000010643 digestive system disease Diseases 0.000 description 1
• PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
• 229940064790 dilantin Drugs 0.000 description 1
• 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 208000032625 disorder of ear Diseases 0.000 description 1
• VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 1
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
• VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
• AMRJKAQTDDKMCE-UHFFFAOYSA-N dolastatin Chemical compound CC(C)C(N(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(C(C)C)C(OC)CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C=1SC=CN=1)CC1=CC=CC=C1 AMRJKAQTDDKMCE-UHFFFAOYSA-N 0.000 description 1
• 229930188854 dolastatin Natural products 0.000 description 1
• 229950004203 droloxifene Drugs 0.000 description 1
• NOTIQUSPUUHHEH-UXOVVSIBSA-N dromostanolone propionate Chemical compound C([C@@H]1CC2)C(=O)[C@H](C)C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](OC(=O)CC)[C@@]2(C)CC1 NOTIQUSPUUHHEH-UXOVVSIBSA-N 0.000 description 1
• 229960004242 dronabinol Drugs 0.000 description 1
• 229950004683 drostanolone propionate Drugs 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 229960005501 duocarmycin Drugs 0.000 description 1
• 229930184221 duocarmycin Natural products 0.000 description 1
• 201000011191 dyskinesia of esophagus Diseases 0.000 description 1
• 208000019258 ear infection Diseases 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 229940011681 elavil Drugs 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 229950000549 elliptinium acetate Drugs 0.000 description 1
• 229940120655 eloxatin Drugs 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 201000008184 embryoma Diseases 0.000 description 1
• 206010014665 endocarditis Diseases 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 230000002357 endometrial effect Effects 0.000 description 1
• 230000003511 endothelial effect Effects 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• JOZGNYDSEBIJDH-UHFFFAOYSA-N eniluracil Chemical compound O=C1NC=C(C#C)C(=O)N1 JOZGNYDSEBIJDH-UHFFFAOYSA-N 0.000 description 1
• 229950010213 eniluracil Drugs 0.000 description 1
• 229950011487 enocitabine Drugs 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 201000000708 eosinophilic esophagitis Diseases 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 201000011114 epidermolysis bullosa acquisita Diseases 0.000 description 1
• 206010015037 epilepsy Diseases 0.000 description 1
• YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 229950002973 epitiostanol Drugs 0.000 description 1
• 229930013356 epothilone Natural products 0.000 description 1
• 150000003883 epothilone derivatives Chemical class 0.000 description 1
• 231100000321 erythema Toxicity 0.000 description 1
• 230000002449 erythroblastic effect Effects 0.000 description 1
• LJQQFQHBKUKHIS-WJHRIEJJSA-N esperamicin Chemical compound O1CC(NC(C)C)C(OC)CC1OC1C(O)C(NOC2OC(C)C(SC)C(O)C2)C(C)OC1OC1C(\C2=C/CSSSC)=C(NC(=O)OC)C(=O)C(OC3OC(C)C(O)C(OC(=O)C=4C(=CC(OC)=C(OC)C=4)NC(=O)C(=C)OC)C3)C2(O)C#C\C=C/C#C1 LJQQFQHBKUKHIS-WJHRIEJJSA-N 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 229960001842 estramustine Drugs 0.000 description 1
• FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 239000000328 estrogen antagonist Substances 0.000 description 1
• 108010038795 estrogen receptors Proteins 0.000 description 1
• 201000009320 ethmoid sinusitis Diseases 0.000 description 1
• 229940009626 etidronate Drugs 0.000 description 1
• 229960000255 exemestane Drugs 0.000 description 1
• 229950011548 fadrozole Drugs 0.000 description 1
• 229940043168 fareston Drugs 0.000 description 1
• 208000022195 farmer lung disease Diseases 0.000 description 1
• 229940087476 femara Drugs 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 208000001031 fetal erythroblastosis Diseases 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 108090000047 fibroblast growth factor 13 Proteins 0.000 description 1
• 102000003684 fibroblast growth factor 13 Human genes 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 230000003890 fistula Effects 0.000 description 1
• 229960000961 floxuridine Drugs 0.000 description 1
• ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
• XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
• 229960004413 flucytosine Drugs 0.000 description 1
• 229960000390 fludarabine Drugs 0.000 description 1
• GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
• 229960002074 flutamide Drugs 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• 229940014144 folate Drugs 0.000 description 1
• 102000006815 folate receptor Human genes 0.000 description 1
• 235000019152 folic acid Nutrition 0.000 description 1
• 239000011724 folic acid Substances 0.000 description 1
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
• 150000002224 folic acids Chemical class 0.000 description 1
• 229960004421 formestane Drugs 0.000 description 1
• OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 229940001490 fosamax Drugs 0.000 description 1
• 229960004783 fotemustine Drugs 0.000 description 1
• YAKWPXVTIGTRJH-UHFFFAOYSA-N fotemustine Chemical compound CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O YAKWPXVTIGTRJH-UHFFFAOYSA-N 0.000 description 1
• 201000006916 frontal sinusitis Diseases 0.000 description 1
• 230000033581 fucosylation Effects 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 208000018685 gastrointestinal system disease Diseases 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 229960005277 gemcitabine Drugs 0.000 description 1
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
• 229940020967 gemzar Drugs 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 230000006589 gland dysfunction Effects 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 229930182470 glycoside Natural products 0.000 description 1
• 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
• 239000002622 gonadotropin Substances 0.000 description 1
• 229960003690 goserelin acetate Drugs 0.000 description 1
• 210000005256 gram-negative cell Anatomy 0.000 description 1
• 201000011580 granulomatous orchitis Diseases 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 239000003966 growth inhibitor Substances 0.000 description 1
• 229960004198 guanidine Drugs 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• 229960002706 gusperimus Drugs 0.000 description 1
• 206010018797 guttate psoriasis Diseases 0.000 description 1
• 150000003278 haem Chemical class 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 208000018706 hematopoietic system disease Diseases 0.000 description 1
• 201000001505 hemoglobinuria Diseases 0.000 description 1
• 230000008588 hemolysis Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 229940022353 herceptin Drugs 0.000 description 1
• 208000003215 hereditary nephritis Diseases 0.000 description 1
• 229940125697 hormonal agent Drugs 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 229940048921 humira Drugs 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 229940088013 hycamtin Drugs 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 1
• 229960004171 hydroxychloroquine Drugs 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• KNOSIOWNDGUGFJ-UHFFFAOYSA-N hydroxysesamone Natural products C1=CC(O)=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1O KNOSIOWNDGUGFJ-UHFFFAOYSA-N 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000003463 hyperproliferative effect Effects 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 230000002989 hypothyroidism Effects 0.000 description 1
• 229940015872 ibandronate Drugs 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 229960000908 idarubicin Drugs 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• DBIGHPPNXATHOF-UHFFFAOYSA-N improsulfan Chemical compound CS(=O)(=O)OCCCNCCCOS(C)(=O)=O DBIGHPPNXATHOF-UHFFFAOYSA-N 0.000 description 1
• 229950008097 improsulfan Drugs 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 229960000905 indomethacin Drugs 0.000 description 1
• 239000000893 inhibin Substances 0.000 description 1
• 108091008042 inhibitory receptors Proteins 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• 150000002484 inorganic compounds Chemical class 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 108010021315 integrin beta7 Proteins 0.000 description 1
• 239000000138 intercalating agent Substances 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229960001388 interferon-beta Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 108090000681 interleukin 20 Proteins 0.000 description 1
• 108040006852 interleukin-4 receptor activity proteins Proteins 0.000 description 1
• 108040006859 interleukin-5 receptor activity proteins Proteins 0.000 description 1
• 108040006862 interleukin-9 receptor activity proteins Proteins 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 208000036971 interstitial lung disease 2 Diseases 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 229960004768 irinotecan Drugs 0.000 description 1
• 201000004614 iritis Diseases 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
• 230000000302 ischemic effect Effects 0.000 description 1
• SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 1
• 208000018937 joint inflammation Diseases 0.000 description 1
• 108010024383 kallikrein 4 Proteins 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 206010023332 keratitis Diseases 0.000 description 1
• 201000010666 keratoconjunctivitis Diseases 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 150000002596 lactones Chemical class 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• CWPGNVFCJOPXFB-UHFFFAOYSA-N lapachol Chemical compound C1=CC=C2C(=O)C(=O)C(CC=C(C)C)=C(O)C2=C1 CWPGNVFCJOPXFB-UHFFFAOYSA-N 0.000 description 1
• SIUGQQMOYSVTAT-UHFFFAOYSA-N lapachol Natural products CC(=CCC1C(O)C(=O)c2ccccc2C1=O)C SIUGQQMOYSVTAT-UHFFFAOYSA-N 0.000 description 1
• 229960004891 lapatinib Drugs 0.000 description 1
• 229960000681 leflunomide Drugs 0.000 description 1
• VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
• 229960003881 letrozole Drugs 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 230000002197 limbic effect Effects 0.000 description 1
• 239000004571 lime Substances 0.000 description 1
• MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
• 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 235000015250 liver sausages Nutrition 0.000 description 1
• 229960002247 lomustine Drugs 0.000 description 1
• 108010031117 low density lipoprotein receptor-related protein 8 Proteins 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000005249 lung adenocarcinoma Diseases 0.000 description 1
• 210000005265 lung cell Anatomy 0.000 description 1
• 201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
• 108010078259 luprolide acetate gel depot Proteins 0.000 description 1
• 229940087857 lupron Drugs 0.000 description 1
• RVFGKBWWUQOIOU-NDEPHWFRSA-N lurtotecan Chemical compound O=C([C@]1(O)CC)OCC(C(N2CC3=4)=O)=C1C=C2C3=NC1=CC=2OCCOC=2C=C1C=4CN1CCN(C)CC1 RVFGKBWWUQOIOU-NDEPHWFRSA-N 0.000 description 1
• 229950002654 lurtotecan Drugs 0.000 description 1
• 230000029849 luteinization Effects 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 208000005158 lymphoid interstitial pneumonia Diseases 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• MQXVYODZCMMZEM-ZYUZMQFOSA-N mannomustine Chemical compound ClCCNC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNCCCl MQXVYODZCMMZEM-ZYUZMQFOSA-N 0.000 description 1
• 229950008612 mannomustine Drugs 0.000 description 1
• 229940099262 marinol Drugs 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000008774 maternal effect Effects 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 201000008836 maxillary sinusitis Diseases 0.000 description 1
• WKPWGQKGSOKKOO-RSFHAFMBSA-N maytansine Chemical compound CO[C@@H]([C@@]1(O)C[C@](OC(=O)N1)([C@H]([C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(C)=O)CC(=O)N1C)C)[H])\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 WKPWGQKGSOKKOO-RSFHAFMBSA-N 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 229960004296 megestrol acetate Drugs 0.000 description 1
• RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 201000008350 membranous glomerulonephritis Diseases 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 208000037819 metastatic cancer Diseases 0.000 description 1
• 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 208000008275 microscopic colitis Diseases 0.000 description 1
• 206010063344 microscopic polyangiitis Diseases 0.000 description 1
• 206010027599 migraine Diseases 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 229960005485 mitobronitol Drugs 0.000 description 1
• 229960003539 mitoguazone Drugs 0.000 description 1
• MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical compound NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 description 1
• 229960000350 mitotane Drugs 0.000 description 1
• 229960001156 mitoxantrone Drugs 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 description 1
• NKAAEMMYHLFEFN-UHFFFAOYSA-M monosodium tartrate Chemical compound [Na+].OC(=O)C(O)C(O)C([O-])=O NKAAEMMYHLFEFN-UHFFFAOYSA-M 0.000 description 1
• 229940072709 motrin Drugs 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 206010065579 multifocal motor neuropathy Diseases 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
• 230000036473 myasthenia Effects 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• 210000004165 myocardium Anatomy 0.000 description 1
• 208000003786 myxedema Diseases 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• IDINUJSAMVOPCM-INIZCTEOSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide Chemical compound NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCN=C(N)N IDINUJSAMVOPCM-INIZCTEOSA-N 0.000 description 1
• NJSMWLQOCQIOPE-OCHFTUDZSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine Chemical compound N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 NJSMWLQOCQIOPE-OCHFTUDZSA-N 0.000 description 1
• BLCLNMBMMGCOAS-UHFFFAOYSA-N n-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amin Chemical compound C1CCC(C(=O)NNC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BLCLNMBMMGCOAS-UHFFFAOYSA-N 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 229950006780 n-acetylglucosamine Drugs 0.000 description 1
• 229940090008 naprosyn Drugs 0.000 description 1
• 229960002009 naproxen Drugs 0.000 description 1
• CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
• CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 229940086322 navelbine Drugs 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 230000027498 negative regulation of mitosis Effects 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 229940053128 nerve growth factor Drugs 0.000 description 1
• 208000008795 neuromyelitis optica Diseases 0.000 description 1
• 229940072228 neurontin Drugs 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 description 1
• 229960002653 nilutamide Drugs 0.000 description 1
• 229960001420 nimustine Drugs 0.000 description 1
• VFEDRRNHLBGPNN-UHFFFAOYSA-N nimustine Chemical compound CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1 VFEDRRNHLBGPNN-UHFFFAOYSA-N 0.000 description 1
• 229940085033 nolvadex Drugs 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 230000001293 nucleolytic effect Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 230000005257 nucleotidylation Effects 0.000 description 1
• 230000000414 obstructive effect Effects 0.000 description 1
• 208000028780 ocular motility disease Diseases 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• CZDBNBLGZNWKMC-MWQNXGTOSA-N olivomycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1)O[C@H]1O[C@@H](C)[C@H](O)[C@@H](OC2O[C@@H](C)[C@H](O)[C@@H](O)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@H](O)[C@H](OC)[C@H](C)O1 CZDBNBLGZNWKMC-MWQNXGTOSA-N 0.000 description 1
• 229950005848 olivomycin Drugs 0.000 description 1
• 229950011093 onapristone Drugs 0.000 description 1
• 229940100688 oral solution Drugs 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000002138 osteoinductive effect Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 229940046231 pamidronate Drugs 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 229960005489 paracetamol Drugs 0.000 description 1
• 239000000199 parathyroid hormone Substances 0.000 description 1
• 229960001319 parathyroid hormone Drugs 0.000 description 1
• 102000045222 parkin Human genes 0.000 description 1
• 229940097097 pediapred Drugs 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 229960001639 penicillamine Drugs 0.000 description 1
• 229950009506 penicillinase Drugs 0.000 description 1
• 210000003899 penis Anatomy 0.000 description 1
• 229960002340 pentostatin Drugs 0.000 description 1
• FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
• QIMGFXOHTOXMQP-GFAGFCTOSA-N peplomycin Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCCN[C@@H](C)C=1C=CC=CC=1)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1NC=NC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C QIMGFXOHTOXMQP-GFAGFCTOSA-N 0.000 description 1
• 229950003180 peplomycin Drugs 0.000 description 1
• 208000011906 peptic ulcer disease Diseases 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 208000029308 periodic paralysis Diseases 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 201000002628 peritoneum cancer Diseases 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 229960002036 phenytoin Drugs 0.000 description 1
• 208000026435 phlegm Diseases 0.000 description 1
• 150000003905 phosphatidylinositols Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 229960000952 pipobroman Drugs 0.000 description 1
• NJBFOOCLYDNZJN-UHFFFAOYSA-N pipobroman Chemical compound BrCCC(=O)N1CCN(C(=O)CCBr)CC1 NJBFOOCLYDNZJN-UHFFFAOYSA-N 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 102000030769 platelet activating factor receptor Human genes 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 150000003057 platinum Chemical class 0.000 description 1
• YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
• 229960001237 podophyllotoxin Drugs 0.000 description 1
• YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 208000030428 polyarticular arthritis Diseases 0.000 description 1
• 108010052780 polyasparagine Proteins 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 208000005987 polymyositis Diseases 0.000 description 1
• 108040000983 polyphosphate:AMP phosphotransferase activity proteins Proteins 0.000 description 1
• 208000006473 polyradiculopathy Diseases 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 239000005373 porous glass Substances 0.000 description 1
• 201000002638 post-cardiac arrest syndrome Diseases 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000003623 progesteronic effect Effects 0.000 description 1
• 229940097325 prolactin Drugs 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 108010087851 prorelaxin Proteins 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 108010043383 protease V Proteins 0.000 description 1
• 229960000856 protein c Drugs 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• WOLQREOUPKZMEX-UHFFFAOYSA-N pteroyltriglutamic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C=C1 WOLQREOUPKZMEX-UHFFFAOYSA-N 0.000 description 1
• 201000009732 pulmonary eosinophilia Diseases 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 206010061928 radiculitis Diseases 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 229960004622 raloxifene Drugs 0.000 description 1
• GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 229960002185 ranimustine Drugs 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 208000034213 recurrent susceptibility to 1 pregnancy loss Diseases 0.000 description 1
• 230000022983 regulation of cell cycle Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 208000009169 relapsing polychondritis Diseases 0.000 description 1
• 239000003488 releasing hormone Substances 0.000 description 1
• 229940116176 remicade Drugs 0.000 description 1
• 230000010410 reperfusion Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 229930002330 retinoic acid Natural products 0.000 description 1
• 230000000552 rheumatic effect Effects 0.000 description 1
• 229940061969 rheumatrex Drugs 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• OWPCHSCAPHNHAV-LMONGJCWSA-N rhizoxin Chemical compound C/C([C@H](OC)[C@@H](C)[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]2/C=C/[C@@H](C)[C@]2([H])OC(=O)C[C@@](C2)(C[C@@H]2O[C@H]2C(=O)O1)[H])=C\C=C\C(\C)=C\C1=COC(C)=N1 OWPCHSCAPHNHAV-LMONGJCWSA-N 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229940089617 risedronate Drugs 0.000 description 1
• XYSQXZCMOLNHOI-UHFFFAOYSA-N s-[2-[[4-(acetylsulfamoyl)phenyl]carbamoyl]phenyl] 5-pyridin-1-ium-1-ylpentanethioate;bromide Chemical compound [Br-].C1=CC(S(=O)(=O)NC(=O)C)=CC=C1NC(=O)C1=CC=CC=C1SC(=O)CCCC[N+]1=CC=CC=C1 XYSQXZCMOLNHOI-UHFFFAOYSA-N 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• 201000000306 sarcoidosis Diseases 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 210000003786 sclera Anatomy 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 231100000879 sensorineural hearing loss Toxicity 0.000 description 1
• 208000023573 sensorineural hearing loss disease Diseases 0.000 description 1
• 201000005572 sensory peripheral neuropathy Diseases 0.000 description 1
• 201000001223 septic arthritis Diseases 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 210000000717 sertoli cell Anatomy 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 229940112726 skelid Drugs 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 201000006923 sphenoid sinusitis Diseases 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• 229950006315 spirogermanium Drugs 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 230000007863 steatosis Effects 0.000 description 1
• 231100000240 steatosis hepatitis Toxicity 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 229960004533 streptodornase Drugs 0.000 description 1
• 229960005202 streptokinase Drugs 0.000 description 1
• 229960001052 streptozocin Drugs 0.000 description 1
• ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
• 238000012916 structural analysis Methods 0.000 description 1
• 208000011834 subacute cutaneous lupus erythematosus Diseases 0.000 description 1
• 201000007497 subacute thyroiditis Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
• 229960001940 sulfasalazine Drugs 0.000 description 1
• 229960000894 sulindac Drugs 0.000 description 1
• MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 description 1
• 229940090016 tegretol Drugs 0.000 description 1
• 208000009056 telangiectasis Diseases 0.000 description 1
• 206010043207 temporal arteritis Diseases 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• 229940071127 thioglycolate Drugs 0.000 description 1
• CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
• 229930192474 thiophene Natural products 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229960001196 thiotepa Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 208000008732 thymoma Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 208000005057 thyrotoxicosis Diseases 0.000 description 1
• 229940034208 thyroxine Drugs 0.000 description 1
• XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
• YFTWHEBLORWGNI-UHFFFAOYSA-N tiamiprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC(N)=NC2=C1NC=N2 YFTWHEBLORWGNI-UHFFFAOYSA-N 0.000 description 1
• 229950011457 tiamiprine Drugs 0.000 description 1
• 229940019375 tiludronate Drugs 0.000 description 1
• 208000037816 tissue injury Diseases 0.000 description 1
• 229960001017 tolmetin Drugs 0.000 description 1
• UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 1
• 229960005026 toremifene Drugs 0.000 description 1
• XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 208000009174 transverse myelitis Diseases 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 description 1
• 229950001353 tretamine Drugs 0.000 description 1
• 229960001727 tretinoin Drugs 0.000 description 1
• 229940111528 trexall Drugs 0.000 description 1
• 229960005294 triamcinolone Drugs 0.000 description 1
• GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
• 229930013292 trichothecene Natural products 0.000 description 1
• 150000003327 trichothecene derivatives Chemical class 0.000 description 1
• 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
• 229960001670 trilostane Drugs 0.000 description 1
• KVJXBPDAXMEYOA-CXANFOAXSA-N trilostane Chemical compound OC1=C(C#N)C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@@]32O[C@@H]31 KVJXBPDAXMEYOA-CXANFOAXSA-N 0.000 description 1
• NOYPYLRCIDNJJB-UHFFFAOYSA-N trimetrexate Chemical compound COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 NOYPYLRCIDNJJB-UHFFFAOYSA-N 0.000 description 1
• 229960001099 trimetrexate Drugs 0.000 description 1
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
• 229950010147 troxacitabine Drugs 0.000 description 1
• RXRGZNYSEHTMHC-BQBZGAKWSA-N troxacitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)OC1 RXRGZNYSEHTMHC-BQBZGAKWSA-N 0.000 description 1
• 101150057627 trxB gene Proteins 0.000 description 1
• HDZZVAMISRMYHH-LITAXDCLSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O HDZZVAMISRMYHH-LITAXDCLSA-N 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• 230000002476 tumorcidal effect Effects 0.000 description 1
• 229950009811 ubenimex Drugs 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 210000001745 uvea Anatomy 0.000 description 1
• 230000006492 vascular dysfunction Effects 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000024883 vasodilation Effects 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 description 1
• 229960002066 vinorelbine Drugs 0.000 description 1
• CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 description 1
• 229920003169 water-soluble polymer Polymers 0.000 description 1
• 238000002424 x-ray crystallography Methods 0.000 description 1
• 229940053867 xeloda Drugs 0.000 description 1
• 229960004276 zoledronic acid Drugs 0.000 description 1
• 229940002005 zometa Drugs 0.000 description 1
• 150000003952 β-lactams Chemical class 0.000 description 1